<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6685390</article-id><article-id pub-id-type="pmcid-ver">PMC6685390.1</article-id><article-id pub-id-type="pmcaid">6685390</article-id><article-id pub-id-type="pmcaiid">6685390</article-id><article-id pub-id-type="pmid">31417562</article-id><article-id pub-id-type="doi">10.3389/fimmu.2019.01787</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Palm</surname><given-names initials="AKE">Anna-Karin E.</given-names></name><xref ref-type="author-notes" rid="fn001"><sup>&#8224;</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/777779/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Henry</surname><given-names initials="C">Carole</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/41760/overview"/></contrib></contrib-group><aff><institution>Section of Rheumatology, Department of Medicine, University of Chicago</institution>, <addr-line>Chicago, IL</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Michael Vajdy, EpitoGenesis, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Johannes Tr&#252;ck, University Children's Hospital Zurich, Switzerland; Claude-Agnes Reynaud, Institut National de la Sant&#233; et de la Recherche M&#233;dicale (INSERM), France</p></fn><corresp id="c001">*Correspondence: Carole Henry <email>carolehenry@uchicago.edu</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Immunological Memory, a section of the journal Frontiers in Immunology</p></fn><fn fn-type="present-address" id="fn001"><p>&#8224;Present address: Anna-Karin E. Palm, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden</p></fn></author-notes><pub-date pub-type="epub"><day>31</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">328186</issue-id><elocation-id>1787</elocation-id><history><date date-type="received"><day>14</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>15</day><month>08</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-08-18 02:56:17.390"><day>18</day><month>08</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2019 Palm and Henry.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Palm and Henry</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-10-01787.pdf"/><abstract><p>The success of vaccines is dependent on the generation and maintenance of immunological memory. The immune system can remember previously encountered pathogens, and memory B and T cells are critical in secondary responses to infection. Studies in mice have helped to understand how different memory B cell populations are generated following antigen exposure and how affinity for the antigen is determinant to B cell fate. Additionally, such studies were fundamental in defining memory B cell niches and how B cells respond following subsequent exposure with the same antigen. On the other hand, human studies are essential to the development of better, newer vaccines but sometimes limited by the difficulty to access primary and secondary lymphoid organs. However, work using human influenza and HIV virus infection and/or immunization in particular has significantly advanced today's understanding of memory B cells. This review will focus on the generation, function, and longevity of B-cell mediated immunological memory (memory B cells and plasma cells) in response to infection and vaccination both in mice and in humans.</p></abstract><kwd-group><kwd>B cell memory</kwd><kwd>vaccination</kwd><kwd>mouse vs. human</kwd><kwd>influenza virus</kwd><kwd>infection</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content></funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="163"/><page-count count="13"/><word-count count="12332"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>One of the hallmarks of our immune system is the ability to &#8220;remember&#8221; past exposure to pathogens. Such exposure can be from infection or vaccination, and by remembering we are, ideally, fully protected from infection upon future encounter with the same pathogen (<xref rid="B1" ref-type="bibr">1</xref>). Although humoral immunological memory is mediated in part by serum antibodies secreted by long-lived plasma cells (LLPCs), these cells are usually not described as memory B cells. Instead, memory B cells are defined as long-lived and quiescent cells that are poised to quickly respond to antigen upon recall (<xref rid="B2" ref-type="bibr">2</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Both memory B cells and antibody-secreting cells (ASCs) are the product of antigen activation and, most often, interaction with cognate T helper cells. They can be IgM<sup>+</sup> or immunoglobulin class-switched, and display germline or affinity-matured antigen receptors (B cell receptors; BCRs) (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B6" ref-type="bibr">6</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>). Although generation of memory B cells does require ligation of CD40 (<xref rid="B9" ref-type="bibr">9</xref>), an early burst of both memory B cells and ASCs can form independently of GCs, as well as in T-cell independent responses (<xref rid="B10" ref-type="bibr">10</xref>&#8211;<xref rid="B16" ref-type="bibr">16</xref>). However, T-cell independent memory responses are beyond the scope of this review and will therefore not be thoroughly discussed here.</p><p>The terminal differentiation of B cells into ASCs is governed by a gene-regulatory network and modified by environmental stimuli as reviewed in Nutt et al. (<xref rid="B17" ref-type="bibr">17</xref>). ASCs can be divided into short-lived ASCs, including short-lived plasma cells and plasmablasts, and LLPCs. Plasmablasts are considered a transient population and can be either precursors of plasma cells (short- and/or long-lived; mainly in mice) or terminally differentiated effector cells activated during ongoing immune responses (mainly in humans) (<xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B23" ref-type="bibr">23</xref>). In mice, within 2&#8211;4 d after infection, plasmablasts are found in extra-follicular zones and differentiate into plasma cells that secrete large quantities of antibodies. This early humoral response of lower affinity usually lasts a few days (<xref rid="B24" ref-type="bibr">24</xref>). In contrast, activation and differentiation of B cells within GCs allow the generation of plasma cells of high affinity that will then migrate to the bone marrow, where they can survive for decades and provide long-term humoral protection (<xref rid="B25" ref-type="bibr">25</xref>). Such LLPCs are key to maintaining long-term humoral immunity after infection or vaccination. They persist in the absence of antigen for decades after the original exposure (<xref rid="B26" ref-type="bibr">26</xref>). Although they exist in multiple lymphoid organs, the bone marrow is the home of the majority of plasma cells in mice (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>).</p><p>Most of what we know about the generation of plasma cells and memory B cells comes from mechanistic studies in mice. Because of massive differences between mice and humans in terms of life span and cell populations/phenotypes, the biology of mouse and human B cells differs. It is therefore important to also look toward <italic toggle="yes">in vivo</italic> lessons we have learned from humans.</p></sec><sec id="s2"><title>Lessons From Mouse Studies</title><sec><title>The Plasma Cell vs. Memory B Cell Fate Decision</title><p>Following antigen activation with a T-dependent antigen, na&#239;ve B cells will interact with cognate T cells at the border between the B- and T-cell zones in the secondary lymphoid organs (<xref ref-type="fig" rid="F1">Figure 1a</xref>). Here, the activated B cells will proliferate and make their first fate decision: whether to differentiate into extrafollicular ASCs or germinal center (GC)-independent memory B cells, or to move deeper into the follicle to form a GC (<xref ref-type="fig" rid="F1">Figure 1b</xref>). A similar choice must then later be made in the light zone (LZ) of the GC, further discussed below. Although the molecular mechanisms for this decision have been extensively studied they have still not been completely elucidated, especially for memory B cell generation. Several studies have addressed the possibility of a &#8220;master transcription factor&#8221; for memory B cell differentiation, similar to Bcl-6 for GC B cells and IRF-4/Blimp-1 for plasma cells (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). Although Bach2, or specifically high expression of Bach2, in LZ GC B cells has been pointed out as a factor promoting differentiation to memory B cells, a transcription factor unique to memory B cells is yet to be found (<xref rid="B31" ref-type="bibr">31</xref>&#8211;<xref rid="B37" ref-type="bibr">37</xref>). As recently reviewed, ZBTB32, KLF2, ABF-1, and STAT5 have been associated with memory B cell generation, but further studies are needed to understand their role (<xref rid="B38" ref-type="bibr">38</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>The generation of memory B cells and plasma cells in a T-dependent response (based on mouse studies). <bold>(a)</bold> Antigen-activation brings B- and T cells in contact at the T-B border in secondary lymphoid organs. <bold>(b)</bold> After initial proliferation in the outer follicle, the B cells make their first fate choice: (1) differentiation into extrafollicular (mostly short-lived) plasma cells (higher affinity), (2) differentiation into very early memory B cells (lower affinity), or (3) up-regulation of Bcl-6 and formation of a germinal center (GC). <bold>(c,d)</bold> In the GC, a similar selection process takes place in the light zone (LZ). Here, high-affinity LZ GC B cells receive strong T-cell help and consequently down-regulate Bach2 and Bcl-6 while turning on the plasma cell transcriptional program (Blimp-1, IRF-4, XBP-1; including up-regulation of CXCR4) <bold>(c)</bold>. The plasma cell precursors will then either enter the circulation as short-lived antibody-secreting cells, or they will upregulate CXCR3, CXCR4, and CXCR5 to allow migration to the bone marrow plasma cell niche <bold>(d)</bold>. Here survival factors produced by stromal cells and other adjacent cells (including eosinophils and macrophages) promote their differentiation into long-lived plasma cells, which continue to secrete antibodies for the duration of the lifetime of the host. <bold>(e,f)</bold> Due to the weaker T-cell help received by low-affinity LZ GC B cells, these will not be instructed to turn on either the plasma cell or the GC B cell transcriptional program. Instead, up-regulation of Bach2, CCR6, EBI2, Ephrin-B1, and IL-9R, together with down-regulation of Bcl-6 and S1PR2, promote differentiation to memory B cells <bold>(e)</bold>. To maximize the likelihood of secondary antigen encounter memory B cells will then position themselves strategically in secondary lymphoid organs, become tissue-resident at the site of infection, or patrol as recirculating cells <bold>(f)</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-01787-g0001.jpg"/></fig><sec><title>Affinity</title><p>There is general consensus in the field that initial affinity for the antigen influences which differentiation pathway will be chosen by an antigen-activated B cell. Newly activated B cells with a relatively high affinity for the antigen will differentiate into short-lived extra-follicular ASCs (<xref rid="B39" ref-type="bibr">39</xref>). This ensures that the first burst of secreted antibody has enough affinity for the antigen to opsonize it and form immune complexes that will be directly cleared by phagocytosis, activate complement, and/or be presented on follicular dendritic cells (FDCs), thereby driving affinity maturation in the GC (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B40" ref-type="bibr">40</xref>). Conversely, antigen-activated B cells of lower affinity typically develop into GC-independent memory B cells. These are most often unmutated and unswitched (IgM+), although class-switched GC-independent memory B cells have been described (<xref rid="B13" ref-type="bibr">13</xref>). The GC-independent memory B cells provide a means of retaining adaptability potential within the memory B cell pool, and these cells can either be recruited later in the same response or recalled upon secondary encounter with the antigen.</p></sec><sec><title>GC Responses</title><p>The third fate choice for antigen-activated B cells is to upregulate Bcl-6 and move deeper into the follicle and start a GC reaction [excellently reviewed in Victora and Nussenzweig (<xref rid="B30" ref-type="bibr">30</xref>), Mesin et al. (<xref rid="B40" ref-type="bibr">40</xref>)]. Briefly, the GC B cells will go through multiple rounds of division in the dark zone (DZ) of the GC, each time introducing mutations in their antigen receptor (B cell receptor; BCR). This process of somatic hypermutation (SHM) leads to affinity maturation and ensures that B cells will specialize their binding to a particular antigen. The mutated B cells will then move to the LZ, where the new BCR will be tested against the antigen presented on FDCs. The B cells that manage to form a BCR with high enough affinity will receive survival signals and either return to the DZ to go through another round of division and SHM, or exit the GC as a plasma cell or a memory B cell.</p><p>Similarly to extrafollicular fate decisions, BCR affinity to the antigen seems to play a role also in the GC (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). High-affinity B cells can bind and endocytose more antigen, and consequently present more antigen-derived peptides on class II MHC (MHCII). This higher density of peptide:MHCII on high-affinity B cells gives them an advantage in competing for access to T-follicular helper (Tfh) cells (<xref rid="B43" ref-type="bibr">43</xref>&#8211;<xref rid="B45" ref-type="bibr">45</xref>). In addition, each interaction with a Tfh cell is prolonged and intensified due to a feed-forward loop depending on peptide:MHCII density and CD40:CD40L ligation (<xref rid="B45" ref-type="bibr">45</xref>). This enhanced CD40:CD40L interaction causes down-regulation of Bcl6 and turning on of IRF-4 in the GC B cells, allowing them to differentiate into Bcl6<sup>lo</sup>CD69<sup>hi</sup> plasma cell precursors before exiting the GC as plasma cells (<xref rid="B46" ref-type="bibr">46</xref>) (<xref ref-type="fig" rid="F1">Figure 1c</xref>). In addition, IL-21 secreted from Tfh cells is required for plasma cell differentiation (<xref rid="B47" ref-type="bibr">47</xref>), further demonstrating the importance of long and strong B:T interactions for this fate decision. A fraction of the plasma cells leaving the GC will home to the bone marrow, where their survival depends on a number of factors in the plasma cell niche (<xref ref-type="fig" rid="F1">Figure 1d</xref>). This will be further discussed below.</p><p>Memory B cells, on the other hand, are generated from low-affinity GC B cells in the LZ and will eventually enter the circulation as patrolling cells or take up residence in lymphoid or target organs (<xref ref-type="fig" rid="F1">Figures 1e,f</xref>). The observation that memory B cells consistently are of lower affinity and have fewer mutations than plasma cells indicate that the former are generated before affinity maturation has allowed for the production of high-affinity BCRs. Indeed, an extensive study shows that memory B cells are formed early in the response whereas LLPCs are a later product (<xref rid="B15" ref-type="bibr">15</xref>). This temporal discrepancy also fits well with the Bach2 dynamics in memory B cells. Bach2 is required for memory B cell differentiation and only early GC B cells express Bach2, with the expression starting to decline from day 10 (<xref rid="B37" ref-type="bibr">37</xref>). Moreover, these experiments show that T cell help, in the form of CD40:CD40L interaction, represses Bach2-expression in GC B cells in a dose-dependent manner. Thus, B cells with higher affinity typically have a lower expression of Bach2 and are therefore predisposed to choose re-entry to the DZ or commitment to the plasma cell transcriptional program. Conversely, relatively weak T cell help, as would be the case for lower-affinity B cells, maintains a relatively high Bach2-expression in LZ B cells, thus favoring a memory B cell fate (<xref rid="B37" ref-type="bibr">37</xref>). It is not clear how Bach2 determines memory B cell fate, but it is believed to act as a suppressor of transcription, particularly of <italic toggle="yes">Prdm1</italic> (encoding Blimp-1) and of pro-apoptotic factors such as Bim and Puma (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B48" ref-type="bibr">48</xref>&#8211;<xref rid="B51" ref-type="bibr">51</xref>). Thus, it seems likely that lack of strong signaling, and consequently lack of instructions to start the plasma cell or GC B cell transcriptional program forces activated B cells into memory fate. Interestingly, memory B cells and na&#239;ve B cells, which are both quiescent with persisting differentiation potential, have similar transcriptional profiles, with the important exception of memory B cells seemingly being hardwired for quick responses (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B52" ref-type="bibr">52</xref>).</p><p>Selection of B cells with a relatively low affinity into the memory compartment early in the response thus ensures that a certain poly-reactivity is maintained within the memory B cell pool. Indeed, preservation of germline, or close to germline, encoded BCRs in memory B cells provides the memory B cell pool with clones that are able to respond quickly while still maintaining a higher degree of flexibility in terms of antigen binding. This flexibility would be lost should only memory B cells with high-affinity mutated BCRs persist in the memory pool. This idea can be illustrated by the observation that around 10% of memory B cells recognize variant antigen better than wild type protein, thus allowing for breadth of protection in a way that LLPCs do not (<xref rid="B53" ref-type="bibr">53</xref>). Conversely, by choosing only the highest-affinity GC B cells for plasma cell fate, the quality of the secreted antibodies is ensured to be very high.</p></sec><sec><title>Immunoglobulin Isotype</title><p>Another proposed determinant factor of plasma cell vs. memory B cell differentiation is immunoglobulin isotype. B cells that have switched to IgG, IgE, or IgA are more prone to differentiate to plasma cells than memory B cells (<xref rid="B54" ref-type="bibr">54</xref>&#8211;<xref rid="B58" ref-type="bibr">58</xref>). Interestingly, a recent study showed that even when B cells are forced to switch to IgG1 independently of AID, thus uncoupling the effects of SHM and class-switch recombination (CSR), the switched GC B cells were predominantly differentiating into plasma cells (<xref rid="B58" ref-type="bibr">58</xref>). Moreover, transcriptional analysis of IgM<sup>+</sup> and IgG1<sup>+</sup> GC B cells in the LZ revealed altered signaling through Nur77 in the switched B cells, associated with increased expression of chemokines associated with exit from the GC into the plasma cell compartment (<xref rid="B58" ref-type="bibr">58</xref>). Together, these studies indicate that intrinsic properties of a non-IgM BCR, probably in their signaling capacity, influences the plasma cell vs. memory B cell fate decision.</p></sec></sec><sec><title>Marking Memory B Cell Precursors</title><p>Studies aiming at defining memory B cell precursors in the GC have found differential expression of several markers on subsets of GC B cells in the LZ. One such marker is the chemokine receptor CCR6, which has been shown to be dispensable for the initial generation but required for correct positioning of memory B cells as well as for optimal recall responses (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). These CCR6<sup>+</sup> GC B cells are generally of lower affinity, and have a phenotype closely resembling that of memory B cells (e.g., up-regulated EBI2 and S1PR1, and down-regulated S1PR2) (<xref rid="B60" ref-type="bibr">60</xref>). A recent study describes a population of Ephrin-B1<sup>high</sup>S1RP2<sup>low</sup> GC B cells as memory precursor cells in the LZ, positioned close to the edge of the GC (<xref rid="B61" ref-type="bibr">61</xref>). In addition, a study focused on plasma cell precursors in the GC LZ proposes that a fraction of GC B cells in the LZ presenting as Bcl6<sup>low</sup>CD69<sup>low</sup> are memory B cell precursors (<xref rid="B46" ref-type="bibr">46</xref>).</p><p>Finally, IL-9R is expressed on memory B cells as well as on a subset of LZ GC B cells concluded to be memory B cell precursors (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). In addition to Bach2-requirement, optimal memory B cell generation also needs Tfh-derived IL-9 (<xref rid="B63" ref-type="bibr">63</xref>), and signaling through IL-9R on memory B cells is required for their recall response (<xref rid="B64" ref-type="bibr">64</xref>). Taken together, memory B cell precursors may be found in the GC LZ and present as CCR6<sup>+</sup>S1PR2<sup>low</sup>Ephrin-B1<sup>high</sup>Bcl6<sup>low</sup>CD69<sup>low</sup>IL-9R<sup>+</sup>. However, further studies are needed to fully elucidate whether this phenotype really corresponds to a committed memory B cell precursor.</p></sec><sec><title>The Memory B-Cell Niche and Recall Responses</title><p>Upon re-exposure to an antigen the memory recall response will be faster, stronger, and more specific than a na&#239;ve response. Protective memory depends first on circulating antibodies secreted by LLPCs (<xref ref-type="fig" rid="F2">Figure 2a</xref>). When these are not sufficient for immediate pathogen neutralization and elimination, memory B cells are recalled. It is therefore of vital functional importance that memory B cells are stationed at strategic sites where they can maximize their chance of encountering antigen (<xref ref-type="fig" rid="F2">Figure 2b</xref>). The spleen, including the marginal zone, is a major reservoir for memory B cells in both mice and humans (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B65" ref-type="bibr">65</xref>&#8211;<xref rid="B67" ref-type="bibr">67</xref>), as is the subcapsular sinus (SCS) of lymph nodes (<xref rid="B68" ref-type="bibr">68</xref>). Both the splenic marginal zone and the lymph node SCS are abundant with CD169+ macrophages, which are specialized in presenting unprocessed antigen to B cells (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>). It has been demonstrated that both na&#239;ve and memory B cells interact with CD169+ macrophages in the SCS, and that upon antigen recall the memory B cells quickly form SCS proliferative foci (<xref ref-type="fig" rid="F2">Figure 2c</xref>), or form new GCs (<xref rid="B68" ref-type="bibr">68</xref>). This was also seen in human lymph nodes. Interestingly, the largest output from the SCS proliferative foci is short-lived plasma cells (ASCs), whereas the new GC is a site for further affinity maturation and CSR with very stringent quality controls that limit plasma cell differentiation (<xref rid="B42" ref-type="bibr">42</xref>). Importantly, both the SCS proliferative foci and the GC also foster memory B cells that may participate in another re-call response or be recruited later in the same response. In addition to the spleen and lymph nodes, memory B cells are found in the bone marrow, Peyers' patches, gingiva, mucosal epithelium of tonsils, the lamina propria of the gastro-intestinal tract, and in the circulation (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B71" ref-type="bibr">71</xref>&#8211;<xref rid="B76" ref-type="bibr">76</xref>). It has not been convincingly demonstrated that the bone marrow, or any other tissue (apart from the spleen and the lymph nodes) contains functional memory B cells or if these memory B cells simply recirculate from the blood to the tissues. These are all anatomical sites where antigen may breach the barriers or be carried to via the circulation, and the memory B cells located here act as sentinels should pre-existing antibodies not provide adequate protection.</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>The memory recall response to secondary antigen exposure. <bold>(a,b)</bold> Pre-existing antibodies secreted by long-lived plasma cells (LLPCs) constitute the first line of defense <bold>(a)</bold>. If this is not sufficient for immediate neutralization and elimination of the antigen, memory B cells will be engaged. This can happen either directly in the affected tissue (tissue-resident memory and circulating memory B cells), or when antigen is carried to secondary lymphoid organs <bold>(b)</bold>. <bold>(c)</bold> Activated B cells in lymph nodes can form subcapsular sinus proliferative foci (SPF) upon antigen-dependent re-activation. Although it is unclear which memory subset constitute the SPF, it is known that the main output is plasmablasts, but that this is also the fostering site for new memory B cells as well as cells entering GCs. <bold>(d&#8211;f)</bold> Depending on their phenotype, different fate decisions will be made by the reactivated memory B cells: new germinal centers (GCs) are typically formed by IgM<sup>+</sup>, usually unmutated, CD80<sup>&#8722;</sup>PD-L2<sup>&#8722;</sup> (double-negative) memory B cells of lower affinity <bold>(d)</bold>. In addition, both IgM<sup>+</sup> and switched memory B cells that express either CD80 or PD-L2 (single-positive) have retained the capacity to seed GCs <bold>(e)</bold>. However, the bulk of these cells, together with some of the IgM<sup>+</sup> double-negative memory B cells, will differentiate directly into plasmablasts <bold>(c,d)</bold>. Finally, switched, high-affinity memory B cells that are double positive for CD80 and PD-L2 exclusively form new plasmablasts <bold>(f)</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-01787-g0002.jpg"/></fig><p>Importantly, memory B cells can also seed sites of infection, where they are maintained as tissue-resident memory B cells (<xref rid="B77" ref-type="bibr">77</xref>&#8211;<xref rid="B79" ref-type="bibr">79</xref>). Here they are quickly activated after pathogen invasion without the need for antigen transportation to draining lymph nodes, thus shortening the time for plasma cell differentiation and antibody production on secondary exposure. Interestingly, in the case of influenza virus infection, broadly reactive memory B cells are enriched in the lung-resident pool, thus conferring quick and cross-reactive protection at the site of infection (<xref rid="B80" ref-type="bibr">80</xref>).</p><p>Upon re-exposure to antigen, memory B cells can quickly proliferate and differentiate into plasma cells. Alternatively, they will re-enter GCs for another round of affinity maturation and CSR. This decision depends on BCR affinity and isotype in addition to differential expression of CD80 and PD-L2 (<xref ref-type="fig" rid="F2">Figures 2d&#8211;f</xref>). These surface markers denote functionally different memory B cells independent of immunoglobulin isotype (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Importantly, the heterogeneity of the memory B cell compartment allows for a functional breadth of memory recall responses.</p><p>Unswitched (i.e., IgM<sup>+</sup>) memory B cells are often derived from GC-independent or very early GC responses. They frequently do not express CD80 and/or PD-L2, and carry few, if any, mutations (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B65" ref-type="bibr">65</xref>). The IgM<sup>+</sup> memory B cell pool thus keeps a breadth of reactivity similar to that of na&#239;ve B cells but with the advantage of being able to rapidly respond to antigen (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B52" ref-type="bibr">52</xref>). This breadth is particularly important for mounting rapid recall responses to variant antigens, such as influenza virus. On the other hand, recalled IgG+ memory B cells tend to rapidly differentiate into plasma cells without re-entering a GC (<xref rid="B4" ref-type="bibr">4</xref>). This is comparable to the fate chosen by switched B cells in the primary GC response (<xref rid="B54" ref-type="bibr">54</xref>&#8211;<xref rid="B58" ref-type="bibr">58</xref>). However, these observations may not be exclusively dependent on immunoglobulin isotype. Indeed, when further dissecting the memory B cell compartment, it becomes apparent that CD80<sup>&#8722;</sup>PD-L2<sup>&#8722;</sup> IgM<sup>+</sup> memory B cells preferentially enter GCs upon recall, whereas those expressing CD80 and/or PD-L2 typically generate rapid IgM<sup>+</sup> and IgG<sup>+</sup> plasma cell responses (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B81" ref-type="bibr">81</xref>). Similarly, IgG<sup>+</sup> memory B cells single-positive for CD80 or PD-L2 can differentiate to ASCs while retaining the capacity to seed GCs, whereas double-positive IgG<sup>+</sup> memory B cells only generate ASCs (<xref rid="B8" ref-type="bibr">8</xref>). These findings are further supported by studies demonstrating that IgG<sup>+</sup> and IgA<sup>+</sup> memory cells can engage in new GC reactions (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B75" ref-type="bibr">75</xref>).</p></sec></sec><sec id="s3"><title>Lessons From Human Studies</title><sec><title>Human Plasmablasts</title><p>In humans, most studies consider plasmablasts as blood short-lived ASCs generated in acute B cell responses to infection or vaccination that transiently contribute to the serum antibody. In a secondary systemic immune response to a protein antigen such as tetanus toxoid or an inactivated influenza virus vaccine, antigen-specific IgG-secreting plasmablasts with somatically mutated VH gene rearrangements are generated from memory B cells (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B82" ref-type="bibr">82</xref>). It is also the case following influenza, Ebola, or Dengue virus infection (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B83" ref-type="bibr">83</xref>&#8211;<xref rid="B85" ref-type="bibr">85</xref>). It remains an open debate whether human plasmablasts are precursors of and how many do become LLPCs. Evidence suggests that once the infection is cleared, the majority of ASCs undergo apoptosis, while a small proportion may go on to further differentiate into LLPCs (<xref rid="B86" ref-type="bibr">86</xref>). The heterogeneity seen in human ASCs from tonsil, blood, and bone marrow reveals stages of increasing maturity, and local profiles of adhesion molecule expression suggest a multi-step model for plasma cell differentiation (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B87" ref-type="bibr">87</xref>). In human blood when plasmablasts appear between days 6 and 8 after vaccination, they are migratory and attracted by CXCL12 and could migrate to tissues, such as the bone marrow (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>).</p><p>Plasmablasts have also been described as a &#8220;steady state&#8221; population where the majority express IgA. They express CCR10 and the adhesion molecule &#946;<sub>7</sub> integrin and they are attracted by CXCL12 suggesting that they come from mucosal immune reactions and can return to mucosal tissue. Approximately 40% of LLPCs in human bone marrow are IgA<sup>+</sup>, non-migratory, and express &#946;<sub>7</sub> integrin and CCR10, suggesting a substantial contribution of mucosal plasma cells to bone marrow resident LLPCs (<xref rid="B90" ref-type="bibr">90</xref>). After tetanus vaccination, IgG<sup>+</sup><inline-formula><mml:math id="M1" overflow="scroll"><mml:msup><mml:mrow><mml:mtext>CD62L</mml:mtext></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> integrin<sup>&#8722;</sup> dividing, vaccine-specific, and migratory plasmablasts appear in the blood, as do non-dividing, non-migratory, CD62L<sup>&#8722;</sup> plasma cells of different specificities (<xref rid="B90" ref-type="bibr">90</xref>).</p><p>A recent study identified survival factors from the bone marrow niche that favors maturation of human blood ASCs to LLPCs <italic toggle="yes">in vitro</italic> (<xref rid="B91" ref-type="bibr">91</xref>). IL-6 and two members of the tumor necrosis factor (TNF) superfamily: BAFF (B-cell activating factor of the TNF family; also known as BLyS in humans) and APRIL (a proliferation-inducing ligand) are known to be important survival signals (<xref rid="B92" ref-type="bibr">92</xref>), as well as is CXCL12 (<xref rid="B93" ref-type="bibr">93</xref>). Additional factors secreted by the bone marrow niche such as fibronectin and YWHAZ are important for LLPC maturation (<xref rid="B91" ref-type="bibr">91</xref>).</p></sec><sec><title>LLPCs</title><sec><title>Migration to and From the Bone Marrow</title><p>Human LLPCs freshly isolated from the bone marrow have high expression of the chemokine receptors CXCR4 and CXCR6 and responsiveness in <italic toggle="yes">in vitro</italic> migration assays to the chemokines CXCL12 and CXCL16. The chemokine CCL28 has also been shown to attract human bone marrow plasma cells <italic toggle="yes">in vitro</italic> (<xref rid="B94" ref-type="bibr">94</xref>). Two interesting populations have been observed in the blood of tetanus toxoid immunized individuals: a population of migratory plasmablasts expressing CXCR3 and CXCR4, and a population resembling mature plasma cells of the bone marrow. These findings suggest that these cells are likely to be resident LLPCs mobilized from their survival niches in the bone marrow, in competition with newly generated plasmablasts (<xref rid="B88" ref-type="bibr">88</xref>).</p></sec><sec><title>In the Bone Marrow</title><p>Mesenchymal stromal cells (MSC) in the human bone marrow microenvironment provide factors that support LLPC survival (<xref rid="B95" ref-type="bibr">95</xref>&#8211;<xref rid="B97" ref-type="bibr">97</xref>). Cytokines of the TNF superfamily (BAFF, APRIL and TNF-&#945;), IL-6 family, CD80/CD86, CD44 binding to hyaluronic acid, and VLA-4 binding to VCAM-1/fibronectin promote survival of plasma cells. CXCL12 promotes entry of cells to the bone marrow as well as plasma cell survival (<xref rid="B86" ref-type="bibr">86</xref>). BAFF seems to be important for human plasmablast differentiation whereas APRIL is the key to long-term survival in the bone marrow (<xref rid="B98" ref-type="bibr">98</xref>). An interesting study demonstrated that extracellular vesicles from bone marrow-derived MSCs support <italic toggle="yes">ex vivo</italic> survival of human ASCs (<xref rid="B99" ref-type="bibr">99</xref>).</p><p>In humans, the bone marrow contains both CD19<sup>+</sup> and CD19<sup><bold>&#8722;</bold></sup> LLPCs (<xref rid="B26" ref-type="bibr">26</xref>). The majority of CD19<sup><bold>&#8722;</bold></sup> LLPCs are actually found in the bone marrow, compared to the blood, spleen and tonsils. Interestingly, CD19<sup><bold>&#8722;</bold></sup> LLPCs are enriched in IgG<sup>+</sup> cells and carry fewer VH mutations compared to CD19<sup>+</sup> LLPCs. Only CD19<sup><bold>&#8722;</bold></sup> LLPCs resist to mobilization into the blood following immunization, and are resistant to depletion by Rituximab. In addition, CD19<sup><bold>&#8722;</bold></sup> LLPCs were not found in the bone marrow of 5&#8211;7 months old infants while CD19<sup>+</sup> LLPCs were present. This study suggests a multi-layer model of LLPCs in the human bone marrow with CD19<sup>+</sup> LLPCs being a dynamic component and CD19<sup><bold>&#8722;</bold></sup> a more static component permitting both adaptation and stability of humoral protection (<xref rid="B100" ref-type="bibr">100</xref>). A more recent study of the same populations but this time in response to influenza virus vaccination suggests that newly generated ASCs can acquire a mature plasma cell phenotype that is accompanied by loss of CD19 expression at an early stage of differentiation, and that aging is not an obligate requirement for a CD19<sup><bold>&#8722;</bold></sup> state to be established (<xref rid="B101" ref-type="bibr">101</xref>). Finally both CD19<sup>+</sup> and CD19<sup>&#8722;</sup> vaccinia-specific LLPCs were detected in the BM more than 35 years after the eradication of smallpox, suggesting that the LLPC pool may be maintained by a process in which vaccinia-specific B cells differentiate into LLPCs in the BM (<xref rid="B26" ref-type="bibr">26</xref>).</p></sec><sec><title>Outside of the Bone Marrow</title><p>Compared to the bone marrow niche, fibroblasts from the lymph nodes and the spleen have been poorly characterized in both mice and humans. A few studies have shown that stromal cells in the spleen and lymph nodes might promote plasma cell survival <italic toggle="yes">in vitro</italic> (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>). Recently, a new subset of fibroblasts (FRCs for fibroblastic reticular cells) in the lymph nodes have been described both in mice and humans as the main cell type in contact with plasma cells to guide them in their migration (<xref rid="B104" ref-type="bibr">104</xref>).</p></sec></sec><sec><title>Mucosal Plasma Cells</title><p>Plasma cells are very abundant in mucosal tissues. They are located both in the connective tissue (lamina propria) and in lymphoid organs such as the tonsils in the oral cavity and Peyer's patches in the gut. The majority of these plasma cells secrete IgA antibodies, and humans also have a substantial IgM<sup>+</sup> plasma cell population in the mucosa (<xref rid="B105" ref-type="bibr">105</xref>). B cells in the respiratory tract and IgA responses in the gastrointestinal tract in have been nicely reviewed in Kato et al. (<xref rid="B106" ref-type="bibr">106</xref>) and Bunker and Bendelac (<xref rid="B107" ref-type="bibr">107</xref>), respectively, and are both beyond the scope of this review.</p></sec><sec><title>Human Memory B Cells</title><p>A great variety of B cell subsets have been identified in the tonsil, spleen, and peripheral blood and represent different stages of development of a naive B cell into a memory B cell. In the human tonsil, at least five distinct subpopulations of mature human B cells (Bm1&#8211;Bm5) have been identified. Concisely, naive B cells belong to the Bm1 and Bm2 subpopulations whereas fully differentiated memory B cells belong to the Bm5 subset (<xref rid="B108" ref-type="bibr">108</xref>&#8211;<xref rid="B110" ref-type="bibr">110</xref>). Interestingly IgG transcripts in the tonsil had accumulated twice as many mutations as the IgM transcripts suggesting that reentry of selected B cells in the GC to generate higher affinity BCRs is a possibility (<xref rid="B109" ref-type="bibr">109</xref>).</p><p>As we previously stated, memory B cells are mainly generated in the GCs in secondary lymphoid organs. After leaving the GCs, memory B cells either join the recirculating pool of lymphocytes, or home to antigen draining sites. Memory B cell niches outside of the blood have been described and memory B cells have been found in the bone marrow, the tonsil and the spleen (<xref rid="B111" ref-type="bibr">111</xref>). Additionally a population of tissue based memory B cells expressing Fc receptor-like 4 (FCRL4) instead of CD27 has been described (<xref rid="B112" ref-type="bibr">112</xref>, <xref rid="B113" ref-type="bibr">113</xref>). In the blood and bone marrow, human memory B cells can be divided in three main populations: CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup> (similar to marginal zone (MZ) B cells), CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>&#8722;</sup> (IgM-ONLY) and class-switched CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>&#8722;</sup> (IgG<sup>+</sup> or IgA<sup>+</sup>) (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B115" ref-type="bibr">115</xref>). An in-depth flow cytometry analysis of human bone marrow and blood samples showed that compared to the blood, the bone marrow was enriched in both MZ and switched B-cells (<xref rid="B116" ref-type="bibr">116</xref>). In the spleen, two main phenotypically distinct B cell populations exist and localize to separate areas of the lymphoid tissue. Mantle zone B cells (IgD<sup>high</sup>IgM<sup>+</sup>CD21<sup>+</sup>CD23<sup>+</sup>) are unmutated and believed to be naive B cells, whereas MZ B cells are IgD<sup>+</sup>IgM<sup>high</sup>CD21<sup>high</sup>CD23<sup>&#177;</sup> and exhibit somatic mutations (<xref rid="B117" ref-type="bibr">117</xref>&#8211;<xref rid="B119" ref-type="bibr">119</xref>). It has been demonstrated that CD148, as well as CD27, are markers for memory B cells present in the human spleen (<xref rid="B120" ref-type="bibr">120</xref>). More recently, a population of IgG<sup>+</sup> memory B cells residing in the MZ of the spleen have been found and examined. IL-21 and BAFF have been demonstrated to be important for the differentiation of these IgG<sup>+</sup> splenic memory B cells into plasma cells (<xref rid="B121" ref-type="bibr">121</xref>).</p><sec><title>CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup> (Also Called Human MZ B Cells)</title><p>The spleen is an important organ in the defense against encapsulated bacteria. A population of &#8220;IgM memory B cells&#8221; controlling <italic toggle="yes">Streptococcus pneumoniae</italic> is observed in the spleen (<xref rid="B122" ref-type="bibr">122</xref>). Additionally, the human peripheral B-cell compartment displays a large CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup> memory B cell population, resembling the splenic MZ B cells. In fact, by CDR3 spectratyping and gene-expression profiling, it has been demonstrated that CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup> memory B cells are circulating splenic MZ B cells. These memory B cells have a mutated BCR, provide a pre-diversified immune repertoire and are involved in T-independent responses (<xref rid="B123" ref-type="bibr">123</xref>). They can develop in the absence of a spleen, but splenectomy in older individuals dramatically reduces the number of blood MZ B cells (<xref rid="B122" ref-type="bibr">122</xref>, <xref rid="B124" ref-type="bibr">124</xref>). Finally, when compared to switched memory B cells in children &lt;2 year of age, CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup> memory B cells in the spleen and blood do not display any signs of antigen-driven activation and expansion despite the many antigenic challenges experienced during childhood, suggesting a developmental diversification outside of T-dependent and T-independent responses (<xref rid="B125" ref-type="bibr">125</xref>).</p></sec><sec><title>CD19<sup>+</sup>CD27<sup>+</sup>IgM<sup>+</sup>IgD<sup>&#8722;</sup> (IgM-Only) and Class-Switched CD19<sup>+</sup>CD27<sup>+</sup>IgM</title><p>By tracking tetanus toxoid-specific memory B cells (CD3<sup><bold>&#8722;</bold></sup>CD19<sup>+</sup>CD20<sup>+</sup>CD27<sup>+</sup>) at steady state, it has been showed that the spleen is the largest reservoir of memory B cells followed by the tonsil. Bone marrow and blood memory B cells express surface IgG and IgA at similar frequencies, while the tonsil contained more IgA memory B cells compared to other locations. IgG<sup>+</sup> memory B cells were enriched in the spleen and the tonsil compared to the bone marrow and the blood and IgM<sup>+</sup>IgD<sup>+</sup> memory B cells were reduced in the tonsil compared to other locations. Interestingly, the absence of spleen and tonsils does not affect secondary responses to tetanus, suggesting an organ independent maintenance and reactivation for human memory B cells (<xref rid="B111" ref-type="bibr">111</xref>). Memory B cells that reside in lymphoid organs and recirculate after re-exposure to antigen are phenotypically the same and do not represent different stages of maturity. Additionally, it has been demonstrated that the human spleen is a major reservoir of long-lived vaccinia-specific memory B cells (<xref rid="B66" ref-type="bibr">66</xref>). Indeed, anti-smallpox IgG<sup>+</sup> memory B cells were specifically enriched in the spleen, confirming that the spleen is a major reservoir for long-lived memory B cells.</p><p>Finally, high-throughput VH sequencing on paired blood and spleen samples revealed that IgM sequences from clones shared between the MZ and the memory IgG/IgA (switched) compartments displayed a mutation and repertoire profile of IgM-only and not of MZ B cells. Thus the &#8220;IgM-only&#8221; subset appears as the only subset showing precursor&#8211;product relationships with CD27<sup>+</sup> switched memory B cells, indicating that they represent GC-derived IgM memory B cells and that IgM-only and MZ B cells constitute two distinct entities (<xref rid="B126" ref-type="bibr">126</xref>).</p></sec></sec><sec><title>Human IgG and IgA Responses Induced by Infection and Vaccination</title><p>The route by which an antigen enters the body (systemic vs. mucosal) and the nature of the antigen are factors that direct the immune response class-switching patterns. Protein antigens usually trigger B cells receiving T-cell help while polysaccharide antigens induce CSR in the absence of T-cell help. Moreover, BAFF and APRIL have been shown to stimulate CSR to IgG and IgA in human B cells (<xref rid="B127" ref-type="bibr">127</xref>). Polysaccharide B cell responses to vaccination in humans have been reviewed in Mitchell et al. (<xref rid="B23" ref-type="bibr">23</xref>), while the kinetics of ASC responses to infection have been reviewed in Carter et al. (<xref rid="B128" ref-type="bibr">128</xref>).</p><sec><title>IgG</title><p>Antibody responses to soluble protein antigens and membrane proteins primarily induce IgG1, but are accompanied with lower levels of the other subclasses. Viral infections in general lead to IgG antibodies of the IgG1 and IgG3 subclasses (<xref rid="B129" ref-type="bibr">129</xref>). On the other hand, antibody responses to bacterial capsular polysaccharide antigens is almost only restricted to IgG2 (<xref rid="B130" ref-type="bibr">130</xref>). IgG4 antibodies are often formed following repeated or long-term exposure to antigen in a non-infectious setting (<xref rid="B131" ref-type="bibr">131</xref>).</p></sec><sec><title>IgA</title><p>Homeostatic IgA responses employ a polyreactive repertoire to bind to a broad subset of microbiota species and tend to be of low affinity. In contrast, mucosal pathogens and vaccines elicit high-affinity, T-cell dependent antibody responses (<xref rid="B107" ref-type="bibr">107</xref>, <xref rid="B132" ref-type="bibr">132</xref>). Mucosal IgA responses through a T-cell dependent reaction that place in mucosal lymphoid follicles, such as intestinal Peyers' patches and mesenteric lymph nodes (together called MALT for Mucosa-Associated Lymphoid Tissues) (<xref rid="B132" ref-type="bibr">132</xref>). Human IgA subtypes show distinct anatomical expression patterns, with monomeric IgA1 dominating in the serum and dimeric IgA2 in the gut (<xref rid="B133" ref-type="bibr">133</xref>).</p><p>Very few studies in humans have compared the induction of IgA and IgG secreting cells following various routes of immunization. An early study compared oral, intranasal and systemic influenza virus vaccines in healthy adults. Both systemic and intranasal immunizations induced mainly IgG<sup>+</sup> influenza-specific B cells in the blood after vaccination while the oral route induced IgA<sup>+</sup> influenza-specific B cells in the blood. Additionally, oral and intranasal administration of antigen-induced IgA influenza-specific antibodies in external secretions (<xref rid="B134" ref-type="bibr">134</xref>). These results were confirmed later on by multiple studies reporting a bursting population of IgG<sup>+</sup> antigen-reactive plasmablasts in the blood after secondary tetanus toxoid vaccination (<xref rid="B88" ref-type="bibr">88</xref>), influenza virus vaccination or infection (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B135" ref-type="bibr">135</xref>), as well as acute dengue virus infection (<xref rid="B22" ref-type="bibr">22</xref>). In addition, immunization of African green monkeys with a live-attenuated H5N1 influenza vaccine resulted in more serum IgG neutralizing antibodies than IgA (<xref rid="B136" ref-type="bibr">136</xref>).</p><p>A study employing Ad26/Env (HIV) vaccination in rhesus macaques demonstrated highly coordinated IgG and IgA responses in both peripheral blood and mucosal compartments (<xref rid="B137" ref-type="bibr">137</xref>). It remains unclear to this day how related IgG and IgA plasmablasts/plasma cells are and what the relationship between mucosal and systemic antibody responses looks like. While a study suggested that mucosal and systemic humoral immune responses are regulated independently of each other based on the observation that systemic vaccination does not seem to impact peripheral IgA<sup>+</sup> plasmablast numbers (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B138" ref-type="bibr">138</xref>), another study revealed that in celiac disease patients, the same antigen-reactive B cell clones that give rise to gut plasma cells also contribute to the serum IgG and IgA antibody pool. However, serum IgA antibodies had a molecular composition (IgA1 vs. IgA2 and J chain level) distinct from that of IgA antibodies secreted in the gut, suggesting the involvement of different plasma cell populations (<xref rid="B139" ref-type="bibr">139</xref>). Finally, analysis of long-term transcriptional profile between blood IgG and IgA influenza-reactive plasmablasts as well as influenza-negative IgA plasmablasts did not reveal any specialization based on isotype. These data suggest that IgG and IgA vaccine&#8211;positive plasmablasts are largely similar, whereas IgA vaccine&#8211;negative plasmablasts appear to be transcriptionally distinct from antigen-induced peripheral blood plasmablasts (<xref rid="B140" ref-type="bibr">140</xref>).</p></sec></sec><sec><title>Lessons From HIV</title><p>Significant efforts in the HIV field are focusing on the design of vaccines that would induce the generation of broadly neutralizing antibodies (bNAbs). Understanding the immunology behind the development of antibody potency and breadth following immunization is crucial in this context, not only to the HIV community (<xref rid="B141" ref-type="bibr">141</xref>). The success of most vaccines relies on the generation of antibodies to provide protection against subsequent infection. As discussed earlier in this review, Tfh cells are critical for the production of high-affinity B cell clones in the GC and thus the generation of long term memory, i.e., memory B cells and LLPCs (<xref rid="B142" ref-type="bibr">142</xref>).</p><p>The feasibility of assessing GCs and Tfh responses from human lymph nodes has been limited, as GC B cells do not circulate in the blood, and lymph nodes are rarely sampled (<xref rid="B143" ref-type="bibr">143</xref>). Recently, fine needle aspirates of the draining lymph nodes were used to longitudinally sample GC B cells and GC Tfh cells in non-human primates. The lymph node fine needle aspiration technique has proven effective in terms of how many cells were recovered from the biopsy as well as in not disrupting the ongoing GC. The authors found that neutralizing antibodies in non-human primates correlate with GC B cell magnitude and Tfh help quality (<xref rid="B144" ref-type="bibr">144</xref>). They also found that GCs peak weeks after the initial immunization. This means that a classic immunization (one injection of antigen) is not optimal for &#8220;feeding&#8221; the peak GC response. Proteins that are not of extreme stability can be degraded, exposing epitopes that would normally be hidden or non-existent on a more native protein conformation. Slow immunogen release could improve the availability of intact antigen and epitopes of interest for the duration of the GC response (<xref rid="B145" ref-type="bibr">145</xref>).</p><p>Germline-targeting strategies aim to activate B cell precursors with potential interest for bNAbs generation, so that they will enter the GC, be selected and affinity matured and will generate memory B cells. Studying HIV-reactive B cell lineages to infer unmutated ancestral BCRs that represent what a na&#239;ve B cell would express is the key to a B-cell lineage vaccine strategy (<xref rid="B146" ref-type="bibr">146</xref>). A vaccination protocol based on B-cell lineage differs from classic protocols in the fact that they may prime with one immunogen and boost with another or with a sequence of several different immunogens (<xref rid="B147" ref-type="bibr">147</xref>&#8211;<xref rid="B150" ref-type="bibr">150</xref>).</p><p>It has been recently demonstrated that only immunogens above a certain affinity and in multimeric form are capable of inducing GCs dominated by B cells from a bNAb precursor starting with low precursor frequency (<xref rid="B151" ref-type="bibr">151</xref>). These B cells successfully competed in GCs, underwent somatic hypermutation and differentiated into memory B cells. Overall this study demonstrates that germline-targeting immunogens can overcome affinity, avidity, and inter-clonal GC competition challenges with high-affinity multimeric designs.</p></sec><sec><title>Lessons From Influenza</title><p>Plasmablasts have been extensively studied in humans, especially in the context of influenza vaccination and infection. Little is known about B cells that become activated but do not differentiate into plasmablasts. A subset of antigen-reactive B cells called ABCs for &#8220;Activated B Cells&#8221; has been described and was found to be transcriptionally distinct from the ASC population and committed to the memory lineage (<xref rid="B152" ref-type="bibr">152</xref>). ABCs and ASCs share hemagglutinin (HA)-reactive clones following influenza vaccination. Our laboratory also described a post-GC population of B cells that phenotypically resemble memory B cells but that have low expression of CD21 (classical memory B cells are CD19<sup>+</sup>CD27<sup>+</sup>CD21<sup>high</sup>). We demonstrated that the CD21<sup>low</sup> population was comprised of recent GC graduates that were refractory to GC reentry and seemed to be predisposed to differentiation into long-lived plasma cells (<xref rid="B153" ref-type="bibr">153</xref>). Although clonally related to memory B cells and plasmablasts, CD21<sup>low</sup> B cells form distinct clades within phylogenetic trees based on the accumulation of variable gene mutations. Another study demonstrated that HA-reactive CD21<sup>low</sup> B cells are enriched in the blood compared to the tissues while there was an enrichment of CD27<sup>+</sup>CD21<sup>high</sup>HA<sup>+</sup> B cells in all tissues. Both CD21<sup>+</sup> and CD21<sup>low</sup> populations were not maintained in the peripheral blood at 1 year post-vaccination (<xref rid="B154" ref-type="bibr">154</xref>).</p><p>Additionally, it is of great interest to understand how different vaccine compositions will affect the generation of memory B cells and LLPCs. Seasonal influenza vaccines exist as live-attenuated influenza virus (LAIV), which more closely resembles natural immunity after infection, or as inactivated vaccines. LAIV have been used mostly in children but do not induce strong systemic antibody responses in adults (<xref rid="B155" ref-type="bibr">155</xref>). The same was true for two different avian pandemic LAIV vaccines (H5N1, H7N9), although these vaccines elicited a long-term immune memory that was revealed after administration of a matched inactivated vaccine (<xref rid="B156" ref-type="bibr">156</xref>&#8211;<xref rid="B158" ref-type="bibr">158</xref>). To understand how LAIV vaccines can prime such a memory response, a detailed analysis of B cell responses in systemic and local lymphoid tissues in a non-human primate model was performed (<xref rid="B136" ref-type="bibr">136</xref>). Interestingly, the authors found that the LAIV vaccine induced robust GCs in the mediastinal (lung-draining) lymph node and that both HA-reactive plasmablasts and memory B cells were found in the mediastinal lymph nodes after immunization.</p><p>Finally, it is believed that adjuvants can modulate humoral responses and retain antigen at the site of injection. Most studies have been done with alum and it remains unknown how other adjuvants (such as AS03 and MF59) act on GCs and antigen release (<xref rid="B159" ref-type="bibr">159</xref>). In the context of influenza vaccines, adjuvanted vaccines administered in patients with impaired immune responses, such as infants and the elderly, were shown to be beneficial (<xref rid="B160" ref-type="bibr">160</xref>&#8211;<xref rid="B162" ref-type="bibr">162</xref>). Additionally a study showed that the adjuvant AS03 induced an increased activation of na&#239;ve B cells and an increased adaptability of recalled memory B cells, improving immunogenicity (<xref rid="B163" ref-type="bibr">163</xref>).</p></sec></sec><sec sec-type="conclusions" id="s4"><title>Conclusion</title><p>The generation of memory B cells and long-lived plasma cells is crucial to the long-term effectiveness of vaccines. Understanding how to induce these different populations and modulate their effects both in animal models and human is essential to the design of better vaccines. Thus, the design of new immunogens, how to release them, as well as the mechanisms of actions of various adjuvants are the future of vaccines protecting against challenging or emerging infectious diseases.</p></sec><sec id="s5"><title>Author Contributions</title><p>A-KP and CH contributed ideas and wrote the review. A-KP designed the figures.</p><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We thank Patrick C. Wilson and Christopher T. Stamper for critical discussion. CH is supported by the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, CEIRS contract HHSN272201400005C.</p></ack><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amanna</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>NE</given-names></name><name name-style="western"><surname>Slifka</surname><given-names>MK</given-names></name></person-group>. <article-title>Duration of humoral immunity to common viral and vaccine antigens</article-title>. <source>N Engl J Med</source>. (<year>2007</year>) <volume>357</volume>:<fpage>1903</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa066092</pub-id><pub-id pub-id-type="pmid">17989383</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dogan</surname><given-names>I</given-names></name><name name-style="western"><surname>Bertocci</surname><given-names>B</given-names></name><name name-style="western"><surname>Vilmont</surname><given-names>V</given-names></name><name name-style="western"><surname>Delbos</surname><given-names>F</given-names></name><name name-style="western"><surname>Megret</surname><given-names>J</given-names></name><name name-style="western"><surname>Storck</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Multiple layers of B cell memory with different effector functions</article-title>. <source>Nat Immunol</source>. (<year>2009</year>) <volume>10</volume>:<fpage>1292</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1814</pub-id><pub-id pub-id-type="pmid">19855380</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Mei</surname><given-names>H</given-names></name><name name-style="western"><surname>Dorner</surname><given-names>T</given-names></name><name name-style="western"><surname>Hiepe</surname><given-names>F</given-names></name><name name-style="western"><surname>Radbruch</surname><given-names>A</given-names></name><name name-style="western"><surname>Fillatreau</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Memory B and memory plasma cells</article-title>. <source>Immunol Rev</source>. (<year>2010</year>) <volume>237</volume>:<fpage>117</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00938.x</pub-id><pub-id pub-id-type="pmid">20727033</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pape</surname><given-names>KA</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Maul</surname><given-names>RW</given-names></name><name name-style="western"><surname>Gearhart</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>MK</given-names></name></person-group>. <article-title>Different B cell populations mediate early and late memory during an endogenous immune response</article-title>. <source>Science</source>. (<year>2011</year>) <volume>331</volume>:<fpage>1203</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.1201730</pub-id><pub-id pub-id-type="pmid">21310965</pub-id><pub-id pub-id-type="pmcid">PMC3993090</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mcheyzer-Williams</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Milpied</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Okitsu</surname><given-names>SL</given-names></name><name name-style="western"><surname>Mcheyzer-Williams</surname><given-names>MG</given-names></name></person-group>. <article-title>Class-switched memory B cells remodel BCRs within secondary germinal centers</article-title>. <source>Nat Immunol</source>. (<year>2015</year>) <volume>16</volume>:<fpage>296</fpage>&#8211;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3095</pub-id><pub-id pub-id-type="pmid">25642821</pub-id><pub-id pub-id-type="pmcid">PMC4333102</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>H</given-names></name><name name-style="western"><surname>Takemori</surname><given-names>T</given-names></name></person-group>. <article-title>Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire</article-title>. <source>Immunity</source>. (<year>2001</year>) <volume>14</volume>:<fpage>181</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00100-5</pub-id><pub-id pub-id-type="pmid">11239450</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomayko</surname><given-names>MM</given-names></name><name name-style="western"><surname>Steinel</surname><given-names>NC</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group>. <article-title>Cutting edge: hierarchy of maturity of murine memory B cell subsets</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>185</volume>:<fpage>7146</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1002163</pub-id><pub-id pub-id-type="pmid">21078902</pub-id><pub-id pub-id-type="pmcid">PMC3133669</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuccarino-Catania</surname><given-names>GV</given-names></name><name name-style="western"><surname>Sadanand</surname><given-names>S</given-names></name><name name-style="western"><surname>Weisel</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Tomayko</surname><given-names>MM</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Kleinstein</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype</article-title>. <source>Nat Immunol</source>. (<year>2014</year>) <volume>15</volume>:<fpage>631</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2914</pub-id><pub-id pub-id-type="pmid">24880458</pub-id><pub-id pub-id-type="pmcid">PMC4105703</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'souza</surname><given-names>L</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>SL</given-names></name><name name-style="western"><surname>Bal</surname><given-names>V</given-names></name><name name-style="western"><surname>Rath</surname><given-names>S</given-names></name><name name-style="western"><surname>George</surname><given-names>A</given-names></name></person-group>. <article-title>CD73 expression identifies a subset of IgM(+) antigen-experienced cells with memory attributes that is T cell and CD40 signalling dependent</article-title>. <source>Immunology</source>. (<year>2017</year>) <volume>152</volume>:<fpage>602</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12800</pub-id><pub-id pub-id-type="pmid">28746783</pub-id><pub-id pub-id-type="pmcid">PMC5680063</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Okada</surname><given-names>S</given-names></name><name name-style="western"><surname>Hatano</surname><given-names>M</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>N</given-names></name><name name-style="western"><surname>Ichii</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells</article-title>. <source>Immunity</source>. (<year>2002</year>) <volume>17</volume>:<fpage>329</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(02)00387-4</pub-id><pub-id pub-id-type="pmid">12354385</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obukhanych</surname><given-names>TV</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group>. <article-title>T-independent type II immune responses generate memory B cells</article-title>. <source>J Exp Med</source>. (<year>2006</year>) <volume>203</volume>:<fpage>305</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20052036</pub-id><pub-id pub-id-type="pmid">16476769</pub-id><pub-id pub-id-type="pmcid">PMC2118207</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaji</surname><given-names>T</given-names></name><name name-style="western"><surname>Ishige</surname><given-names>A</given-names></name><name name-style="western"><surname>Hikida</surname><given-names>M</given-names></name><name name-style="western"><surname>Taka</surname><given-names>J</given-names></name><name name-style="western"><surname>Hijikata</surname><given-names>A</given-names></name><name name-style="western"><surname>Kubo</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory</article-title>. <source>J Exp Med</source>. (<year>2012</year>) <volume>209</volume>:<fpage>2079</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20120127</pub-id><pub-id pub-id-type="pmid">23027924</pub-id><pub-id pub-id-type="pmcid">PMC3478929</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Pape</surname><given-names>KA</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>MK</given-names></name></person-group>. <article-title>A germinal center-independent pathway generates unswitched memory B cells early in the primary response</article-title>. <source>J Exp Med</source>. (<year>2012</year>) <volume>209</volume>:<fpage>597</fpage>&#8211;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20111696</pub-id><pub-id pub-id-type="pmid">22370719</pub-id><pub-id pub-id-type="pmcid">PMC3302224</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takemori</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaji</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimoda</surname><given-names>M</given-names></name><name name-style="western"><surname>Rajewsky</surname><given-names>K</given-names></name></person-group>. <article-title>Generation of memory B cells inside and outside germinal centers</article-title>. <source>Eur J Immunol</source>. (<year>2014</year>) <volume>44</volume>:<fpage>1258</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201343716</pub-id><pub-id pub-id-type="pmid">24610726</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weisel</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Zuccarino-Catania</surname><given-names>GV</given-names></name><name name-style="western"><surname>Chikina</surname><given-names>M</given-names></name><name name-style="western"><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group>. <article-title>A temporal switch in the germinal center determines differential output of memory B and plasma cells</article-title>. <source>Immunity</source>. (<year>2016</year>) <volume>44</volume>:<fpage>116</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.12.004</pub-id><pub-id pub-id-type="pmid">26795247</pub-id><pub-id pub-id-type="pmcid">PMC4724390</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pape</surname><given-names>KA</given-names></name><name name-style="western"><surname>Maul</surname><given-names>RW</given-names></name><name name-style="western"><surname>Dileepan</surname><given-names>T</given-names></name><name name-style="western"><surname>Paustian</surname><given-names>AS</given-names></name><name name-style="western"><surname>Gearhart</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>MK</given-names></name></person-group>. <article-title>Naive B cells with high-avidity germline-encoded antigen receptors produce persistent IgM(+) and transient IgG(+) memory B cells</article-title>. <source>Immunity.</source> (<year>2018</year>) <volume>48</volume>:<fpage>1135</fpage>&#8211;<lpage>43 e1134</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.04.019</pub-id><pub-id pub-id-type="pmid">29884459</pub-id><pub-id pub-id-type="pmcid">PMC6052797</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nutt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Hodgkin</surname><given-names>PD</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>LM</given-names></name></person-group>. <article-title>The generation of antibody-secreting plasma cells</article-title>. <source>Nat Rev Immunol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>160</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nri3795</pub-id><pub-id pub-id-type="pmid">25698678</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kallies</surname><given-names>A</given-names></name><name name-style="western"><surname>Hasbold</surname><given-names>J</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Dietrich</surname><given-names>W</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>LM</given-names></name><name name-style="western"><surname>Hodgkin</surname><given-names>PD</given-names></name><etal/></person-group>. <article-title>Plasma cell ontogeny defined by quantitative changes in blimp-1 expression</article-title>. <source>J Exp Med</source>. (<year>2004</year>) <volume>200</volume>:<fpage>967</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20040973</pub-id><pub-id pub-id-type="pmid">15492122</pub-id><pub-id pub-id-type="pmcid">PMC2211847</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blink</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Light</surname><given-names>A</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Hodgkin</surname><given-names>PD</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name></person-group>. <article-title>Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization</article-title>. <source>J Exp Med</source>. (<year>2005</year>) <volume>201</volume>:<fpage>545</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20042060</pub-id><pub-id pub-id-type="pmid">15710653</pub-id><pub-id pub-id-type="pmcid">PMC2213050</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wrammert</surname><given-names>J</given-names></name><name name-style="western"><surname>Smith</surname><given-names>K</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J</given-names></name><name name-style="western"><surname>Langley</surname><given-names>WA</given-names></name><name name-style="western"><surname>Kokko</surname><given-names>K</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Rapid cloning of high-affinity human monoclonal antibodies against influenza virus</article-title>. <source>Nature</source>. (<year>2008</year>) <volume>453</volume>:<fpage>667</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nature06890</pub-id><pub-id pub-id-type="pmid">18449194</pub-id><pub-id pub-id-type="pmcid">PMC2515609</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>C</given-names></name><name name-style="western"><surname>Eun-Hyung Lee</surname><given-names>F</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J</given-names></name><name name-style="western"><surname>Halliley</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data</article-title>. <source>Cytometry B Clin Cytom.</source> (<year>2010</year>) <issue>78 Suppl</issue><volume>1</volume>:<fpage>S69</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.b.20554</pub-id><pub-id pub-id-type="pmcid">PMC3084630</pub-id><pub-id pub-id-type="pmid">20839340</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wrammert</surname><given-names>J</given-names></name><name name-style="western"><surname>Onlamoon</surname><given-names>N</given-names></name><name name-style="western"><surname>Akondy</surname><given-names>RS</given-names></name><name name-style="western"><surname>Perng</surname><given-names>GC</given-names></name><name name-style="western"><surname>Polsrila</surname><given-names>K</given-names></name><name name-style="western"><surname>Chandele</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans</article-title>. <source>J Virol</source>. (<year>2012</year>) <volume>86</volume>:<fpage>2911</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.06075-11</pub-id><pub-id pub-id-type="pmid">22238318</pub-id><pub-id pub-id-type="pmcid">PMC3302324</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>R</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>DF</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Truck</surname><given-names>J</given-names></name></person-group>. <article-title>Polysaccharide-specific B cell responses to vaccination in humans</article-title>. <source>Hum Vaccin Immunother</source>. (<year>2014</year>) <volume>10</volume>:<fpage>1661</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4161/hv.28350</pub-id><pub-id pub-id-type="pmid">24632599</pub-id><pub-id pub-id-type="pmcid">PMC5396230</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name></person-group>. <article-title>Staying alive: regulation of plasma cell survival</article-title>. <source>Trends Immunol</source>. (<year>2011</year>) <volume>32</volume>:<fpage>595</fpage>&#8211;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2011.09.001</pub-id><pub-id pub-id-type="pmid">22001488</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zehentmeier</surname><given-names>S</given-names></name><name name-style="western"><surname>Roth</surname><given-names>K</given-names></name><name name-style="western"><surname>Cseresnyes</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sercan</surname><given-names>O</given-names></name><name name-style="western"><surname>Horn</surname><given-names>K</given-names></name><name name-style="western"><surname>Niesner</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells</article-title>. <source>Eur J Immunol</source>. (<year>2014</year>) <volume>44</volume>:<fpage>2306</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201344313</pub-id><pub-id pub-id-type="pmid">24777940</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brynjolfsson</surname><given-names>SF</given-names></name><name name-style="western"><surname>Mohaddes</surname><given-names>M</given-names></name><name name-style="western"><surname>Karrholm</surname><given-names>J</given-names></name><name name-style="western"><surname>Wick</surname><given-names>MJ</given-names></name></person-group>. <article-title>Long-lived plasma cells in human bone marrow can be either CD19(+) or CD19(&#8722;)</article-title>. <source>Blood Adv</source>. (<year>2017</year>) <volume>1</volume>:<fpage>835</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2017004481</pub-id><pub-id pub-id-type="pmid">29296727</pub-id><pub-id pub-id-type="pmcid">PMC5727810</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benner</surname><given-names>R</given-names></name><name name-style="western"><surname>Hijmans</surname><given-names>W</given-names></name><name name-style="western"><surname>Haaijman</surname><given-names>JJ</given-names></name></person-group>. <article-title>The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation</article-title>. <source>Clin Exp Immunol</source>. (<year>1981</year>) <volume>46</volume>:<fpage>1</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="pmid">7039877</pub-id><pub-id pub-id-type="pmcid">PMC1536329</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slifka</surname><given-names>MK</given-names></name><name name-style="western"><surname>Matloubian</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Bone marrow is a major site of long-term antibody production after acute viral infection</article-title>. <source>J Virol</source>. (<year>1995</year>) <volume>69</volume>:<fpage>1895</fpage>&#8211;<lpage>902</lpage>. <pub-id pub-id-type="pmid">7853531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jvi.69.3.1895-1902.1995</pub-id><pub-id pub-id-type="pmcid">PMC188803</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nutt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Taubenheim</surname><given-names>N</given-names></name><name name-style="western"><surname>Hasbold</surname><given-names>J</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>LM</given-names></name><name name-style="western"><surname>Hodgkin</surname><given-names>PD</given-names></name></person-group>. <article-title>The genetic network controlling plasma cell differentiation</article-title>. <source>Semin Immunol</source>. (<year>2011</year>) <volume>23</volume>:<fpage>341</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2011.08.010</pub-id><pub-id pub-id-type="pmid">21924923</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Victora</surname><given-names>GD</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group>. <article-title>Germinal centers</article-title>. <source>Ann Rev Immunol</source>. (<year>2012</year>) <volume>30</volume>:<fpage>429</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075032</pub-id><pub-id pub-id-type="pmid">22224772</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>U</given-names></name><name name-style="western"><surname>Tu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Stolovitzky</surname><given-names>GA</given-names></name><name name-style="western"><surname>Keller</surname><given-names>JL</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>JJr</given-names></name><name name-style="western"><surname>Miljkovic</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Transcriptional analysis of the B cell germinal center reaction</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2003</year>) <volume>100</volume>:<fpage>2639</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0437996100</pub-id><pub-id pub-id-type="pmid">12604779</pub-id><pub-id pub-id-type="pmcid">PMC151393</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>U</given-names></name><name name-style="western"><surname>Tu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Stolovitzky</surname><given-names>GA</given-names></name><name name-style="western"><surname>Keller</surname><given-names>JL</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>JJr</given-names></name><name name-style="western"><surname>Miljkovic</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Gene expression dynamics during germinal center transit in B cells</article-title>. <source>Ann N Y Acad Sci</source>. (<year>2003</year>) <volume>987</volume>:<fpage>166</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2003.tb06045.x</pub-id><pub-id pub-id-type="pmid">12727636</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharya</surname><given-names>D</given-names></name><name name-style="western"><surname>Cheah</surname><given-names>MT</given-names></name><name name-style="western"><surname>Franco</surname><given-names>CB</given-names></name><name name-style="western"><surname>Hosen</surname><given-names>N</given-names></name><name name-style="western"><surname>Pin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Sha</surname><given-names>WC</given-names></name><etal/></person-group>. <article-title>Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation</article-title>. <source>J Immunol</source>. (<year>2007</year>) <volume>179</volume>:<fpage>6808</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.179.10.6808</pub-id><pub-id pub-id-type="pmid">17982071</pub-id><pub-id pub-id-type="pmcid">PMC4517294</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Good</surname><given-names>KL</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name></person-group>. <article-title>Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2007</year>) <volume>104</volume>:<fpage>13420</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0703872104</pub-id><pub-id pub-id-type="pmid">17673551</pub-id><pub-id pub-id-type="pmcid">PMC1948953</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomayko</surname><given-names>MM</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Brayton</surname><given-names>CE</given-names></name><name name-style="western"><surname>Sadanand</surname><given-names>S</given-names></name><name name-style="western"><surname>Steinel</surname><given-names>NC</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>TW</given-names></name><etal/></person-group>. <article-title>Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities</article-title>. <source>J Immunol</source>. (<year>2008</year>) <volume>181</volume>:<fpage>27</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.1.27</pub-id><pub-id pub-id-type="pmid">18566367</pub-id><pub-id pub-id-type="pmcid">PMC4437802</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Good</surname><given-names>KL</given-names></name><name name-style="western"><surname>Avery</surname><given-names>DT</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name></person-group>. <article-title>Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>182</volume>:<fpage>890</fpage>&#8211;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.182.2.890</pub-id><pub-id pub-id-type="pmid">19124732</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinnakasu</surname><given-names>R</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Kometani</surname><given-names>K</given-names></name><name name-style="western"><surname>Moriyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Regulated selection of germinal-center cells into the memory B cell compartment</article-title>. <source>Nat Immunol</source>. (<year>2016</year>) <volume>17</volume>:<fpage>861</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3460</pub-id><pub-id pub-id-type="pmid">27158841</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Matthias</surname><given-names>PD</given-names></name></person-group>. <article-title>The transcriptional regulation of germinal center formation</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>2026</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02026</pub-id><pub-id pub-id-type="pmid">30233601</pub-id><pub-id pub-id-type="pmcid">PMC6134015</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paus</surname><given-names>D</given-names></name><name name-style="western"><surname>Phan</surname><given-names>TG</given-names></name><name name-style="western"><surname>Chan</surname><given-names>TD</given-names></name><name name-style="western"><surname>Gardam</surname><given-names>S</given-names></name><name name-style="western"><surname>Basten</surname><given-names>A</given-names></name><name name-style="western"><surname>Brink</surname><given-names>R</given-names></name></person-group>. <article-title>Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation</article-title>. <source>J Exp Med</source>. (<year>2006</year>) <volume>203</volume>:<fpage>1081</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20060087</pub-id><pub-id pub-id-type="pmid">16606676</pub-id><pub-id pub-id-type="pmcid">PMC2118299</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mesin</surname><given-names>L</given-names></name><name name-style="western"><surname>Ersching</surname><given-names>J</given-names></name><name name-style="western"><surname>Victora</surname><given-names>GD</given-names></name></person-group>. <article-title>Germinal Center B Cell Dynamics</article-title>. <source>Immunity</source>. (<year>2016</year>) <volume>45</volume>:<fpage>471</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.001</pub-id><pub-id pub-id-type="pmid">27653600</pub-id><pub-id pub-id-type="pmcid">PMC5123673</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>KG</given-names></name><name name-style="western"><surname>Light</surname><given-names>A</given-names></name><name name-style="western"><surname>Nossal</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name></person-group>. <article-title>The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response</article-title>. <source>EMBO J</source>. (<year>1997</year>) <volume>16</volume>:<fpage>2996</fpage>&#8211;<lpage>3006</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.11.2996</pub-id><pub-id pub-id-type="pmid">9214617</pub-id><pub-id pub-id-type="pmcid">PMC1169918</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phan</surname><given-names>TG</given-names></name><name name-style="western"><surname>Paus</surname><given-names>D</given-names></name><name name-style="western"><surname>Chan</surname><given-names>TD</given-names></name><name name-style="western"><surname>Turner</surname><given-names>ML</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Basten</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>High affinity germinal center B cells are actively selected into the plasma cell compartment</article-title>. <source>J Exp Med</source>. (<year>2006</year>) <volume>203</volume>:<fpage>2419</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20061254</pub-id><pub-id pub-id-type="pmid">17030950</pub-id><pub-id pub-id-type="pmcid">PMC2118125</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burbach</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Medeiros</surname><given-names>RB</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>KL</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>Y</given-names></name></person-group>. <article-title>T-cell receptor signaling to integrins</article-title>. <source>Immunol Rev</source>. (<year>2007</year>) <volume>218</volume>:<fpage>65</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00527.x</pub-id><pub-id pub-id-type="pmid">17624944</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Victora</surname><given-names>GD</given-names></name><name name-style="western"><surname>Schwickert</surname><given-names>TA</given-names></name><name name-style="western"><surname>Fooksman</surname><given-names>DR</given-names></name><name name-style="western"><surname>Kamphorst</surname><given-names>AO</given-names></name><name name-style="western"><surname>Meyer-Hermann</surname><given-names>M</given-names></name><name name-style="western"><surname>Dustin</surname><given-names>ML</given-names></name><etal/></person-group>. <article-title>Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter</article-title>. <source>Cell</source>. (<year>2010</year>) <volume>143</volume>:<fpage>592</fpage>&#8211;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.10.032</pub-id><pub-id pub-id-type="pmid">21074050</pub-id><pub-id pub-id-type="pmcid">PMC3035939</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shih</surname><given-names>C</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction</article-title>. <source>Nature</source>. (<year>2015</year>) <volume>517</volume>:<fpage>214</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature13803</pub-id><pub-id pub-id-type="pmid">25317561</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ise</surname><given-names>W</given-names></name><name name-style="western"><surname>Fujii</surname><given-names>K</given-names></name><name name-style="western"><surname>Shiroguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Ito</surname><given-names>A</given-names></name><name name-style="western"><surname>Kometani</surname><given-names>K</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>T follicular helper cell-germinal center B cell interaction strength regulates entry into plasma cell or recycling germinal center cell fate</article-title>. <source>Immunity.</source> (<year>2018</year>) <volume>48</volume>:<fpage>702</fpage>&#8211;<lpage>715 e704</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.03.027</pub-id><pub-id pub-id-type="pmid">29669250</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zotos</surname><given-names>D</given-names></name><name name-style="western"><surname>Coquet</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Light</surname><given-names>A</given-names></name><name name-style="western"><surname>D'costa</surname><given-names>K</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism</article-title>. <source>J Exp Med.</source> (<year>2010</year>) <volume>207</volume>:<fpage>365</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091777</pub-id><pub-id pub-id-type="pmid">20142430</pub-id><pub-id pub-id-type="pmcid">PMC2822601</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muto</surname><given-names>A</given-names></name><name name-style="western"><surname>Tashiro</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>O</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>H</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sakoda</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>The transcriptional programme of antibody class switching involves the repressor Bach2</article-title>. <source>Nature</source>. (<year>2004</year>) <volume>429</volume>:<fpage>566</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nature02596</pub-id><pub-id pub-id-type="pmid">15152264</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>SF</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>O'donnell</surname><given-names>K</given-names></name><name name-style="western"><surname>Light</surname><given-names>A</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group>. <article-title>Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells</article-title>. <source>Blood</source>. (<year>2007</year>) <volume>110</volume>:<fpage>3978</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-05-091306</pub-id><pub-id pub-id-type="pmid">17720882</pub-id><pub-id pub-id-type="pmcid">PMC2190612</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Igarashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Ochiai</surname><given-names>K</given-names></name><name name-style="western"><surname>Muto</surname><given-names>A</given-names></name></person-group>. <article-title>Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation</article-title>. <source>J Biochem</source>. (<year>2007</year>) <volume>141</volume>:<fpage>783</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvm106</pub-id><pub-id pub-id-type="pmid">17569706</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clybouw</surname><given-names>C</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>S</given-names></name><name name-style="western"><surname>Auffredou</surname><given-names>MT</given-names></name><name name-style="western"><surname>Hugues</surname><given-names>P</given-names></name><name name-style="western"><surname>Alexia</surname><given-names>C</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Regulation of memory B-cell survival by the BH3-only protein Puma</article-title>. <source>Blood</source>. (<year>2011</year>) <volume>118</volume>:<fpage>4120</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-04-347096</pub-id><pub-id pub-id-type="pmid">21868573</pub-id><pub-id pub-id-type="pmcid">PMC3204730</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name><name name-style="western"><surname>Avery</surname><given-names>DT</given-names></name><name name-style="western"><surname>Deenick</surname><given-names>EK</given-names></name><name name-style="western"><surname>Hodgkin</surname><given-names>PD</given-names></name></person-group>. <article-title>Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses</article-title>. <source>J Immunol</source>. (<year>2003</year>) <volume>170</volume>:<fpage>686</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.2.686</pub-id><pub-id pub-id-type="pmid">12517929</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purtha</surname><given-names>WE</given-names></name><name name-style="western"><surname>Tedder</surname><given-names>TF</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>D</given-names></name><name name-style="western"><surname>Diamond</surname><given-names>MS</given-names></name></person-group><article-title>Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants</article-title>. <source>J Exp Med</source>. (<year>2011</year>) <volume>208</volume>:<fpage>2599</fpage>&#8211;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20110740</pub-id><pub-id pub-id-type="pmid">22162833</pub-id><pub-id pub-id-type="pmcid">PMC3244041</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erazo</surname><given-names>A</given-names></name><name name-style="western"><surname>Kutchukhidze</surname><given-names>N</given-names></name><name name-style="western"><surname>Leung</surname><given-names>M</given-names></name><name name-style="western"><surname>Christ</surname><given-names>AP</given-names></name><name name-style="western"><surname>Urban</surname><given-names>JFJr</given-names></name><name name-style="western"><surname>Curotto De Lafaille</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Unique maturation program of the IgE response <italic toggle="yes">in vivo</italic></article-title>. <source>Immunity</source>. (<year>2007</year>) <volume>26</volume>:<fpage>191</fpage>&#8211;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2006.12.006</pub-id><pub-id pub-id-type="pmid">17292640</pub-id><pub-id pub-id-type="pmcid">PMC1892589</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duchez</surname><given-names>S</given-names></name><name name-style="western"><surname>Amin</surname><given-names>R</given-names></name><name name-style="western"><surname>Cogne</surname><given-names>N</given-names></name><name name-style="western"><surname>Delpy</surname><given-names>L</given-names></name><name name-style="western"><surname>Sirac</surname><given-names>C</given-names></name><name name-style="western"><surname>Pascal</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2010</year>) <volume>107</volume>:<fpage>3064</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0912393107</pub-id><pub-id pub-id-type="pmid">20133609</pub-id><pub-id pub-id-type="pmcid">PMC2840347</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>BM</given-names></name><name name-style="western"><surname>Allen</surname><given-names>CD</given-names></name></person-group>. <article-title>Fluorescent <italic toggle="yes">in vivo</italic> detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition</article-title>. <source>Immunity</source>. (<year>2012</year>) <volume>36</volume>:<fpage>857</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.02.009</pub-id><pub-id pub-id-type="pmid">22406270</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>SK</given-names></name><etal/></person-group>. <article-title>No receptor stands alone: IgG B-cell receptor intrinsic and extrinsic mechanisms contribute to antibody memory</article-title>. <source>Cell Res</source>. (<year>2014</year>) <volume>24</volume>:<fpage>651</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2014.65</pub-id><pub-id pub-id-type="pmid">24839903</pub-id><pub-id pub-id-type="pmcid">PMC4042179</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gitlin</surname><given-names>AD</given-names></name><name name-style="western"><surname>Von Boehmer</surname><given-names>L</given-names></name><name name-style="western"><surname>Gazumyan</surname><given-names>A</given-names></name><name name-style="western"><surname>Shulman</surname><given-names>Z</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>TY</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group>. <article-title>Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory</article-title>. <source>Immunity</source>. (<year>2016</year>) <volume>44</volume>:<fpage>769</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.011</pub-id><pub-id pub-id-type="pmid">26944202</pub-id><pub-id pub-id-type="pmcid">PMC4838502</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elgueta</surname><given-names>R</given-names></name><name name-style="western"><surname>Marks</surname><given-names>E</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>E</given-names></name><name name-style="western"><surname>Menezes</surname><given-names>S</given-names></name><name name-style="western"><surname>Benson</surname><given-names>M</given-names></name><name name-style="western"><surname>Raman</surname><given-names>VS</given-names></name><etal/></person-group>. <article-title>CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen</article-title>. <source>J Immunol</source>. (<year>2015</year>) <volume>194</volume>:<fpage>505</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1401553</pub-id><pub-id pub-id-type="pmid">25505290</pub-id><pub-id pub-id-type="pmcid">PMC4282958</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suan</surname><given-names>D</given-names></name><name name-style="western"><surname>Krautler</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Maag</surname><given-names>JLV</given-names></name><name name-style="western"><surname>Butt</surname><given-names>D</given-names></name><name name-style="western"><surname>Bourne</surname><given-names>K</given-names></name><name name-style="western"><surname>Hermes</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>CCR6 defines memory B cell precursors in mouse and human germinal centers, revealing light-zone location and predominant low antigen affinity</article-title>. <source>Immunity.</source> (<year>2017</year>) <volume>47</volume>:<fpage>1142</fpage>&#8211;<lpage>53 e1144</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.022</pub-id><pub-id pub-id-type="pmid">29262350</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laidlaw</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>TH</given-names></name><name name-style="western"><surname>Green</surname><given-names>JA</given-names></name><name name-style="western"><surname>Allen</surname><given-names>CD</given-names></name><name name-style="western"><surname>Okada</surname><given-names>T</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>The Eph-related tyrosine kinase ligand Ephrin-B1 marks germinal center and memory precursor B cells</article-title>. <source>J Exp Med</source>. (<year>2017</year>) <volume>214</volume>:<fpage>639</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20161461</pub-id><pub-id pub-id-type="pmid">28143955</pub-id><pub-id pub-id-type="pmcid">PMC5339677</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fawaz</surname><given-names>LM</given-names></name><name name-style="western"><surname>Sharif-Askari</surname><given-names>E</given-names></name><name name-style="western"><surname>Hajoui</surname><given-names>O</given-names></name><name name-style="western"><surname>Soussi-Gounni</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamid</surname><given-names>Q</given-names></name><name name-style="western"><surname>Mazer</surname><given-names>BD</given-names></name></person-group>. <article-title>Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2007</year>) <volume>120</volume>:<fpage>1208</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2007.08.022</pub-id><pub-id pub-id-type="pmid">17919707</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells</article-title>. <source>Nat Immunol</source>. (<year>2017</year>) <volume>18</volume>:<fpage>921</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3788</pub-id><pub-id pub-id-type="pmid">28650481</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takatsuka</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name><name name-style="western"><surname>Haniuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Saruwatari</surname><given-names>H</given-names></name><name name-style="western"><surname>Ichihashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Renauld</surname><given-names>J-C</given-names></name><etal/></person-group>. <article-title>IL-9 receptor signaling in memory B cells regulates humoral recall responses</article-title>. <source>Nat Immunol</source>. (<year>2018</year>) <volume>19</volume>:<fpage>1025</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-018-0177-0</pub-id><pub-id pub-id-type="pmid">30082831</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tomayko</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ahuja</surname><given-names>A</given-names></name><name name-style="western"><surname>Haberman</surname><given-names>AM</given-names></name><name name-style="western"><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group>. <article-title>New markers for murine memory B cells that define mutated and unmutated subsets</article-title>. <source>J Exp Med</source>. (<year>2007</year>) <volume>204</volume>:<fpage>2103</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20062571</pub-id><pub-id pub-id-type="pmid">17698588</pub-id><pub-id pub-id-type="pmcid">PMC2118690</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamani-Matsuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Cosma</surname><given-names>A</given-names></name><name name-style="western"><surname>Weller</surname><given-names>S</given-names></name><name name-style="western"><surname>Faili</surname><given-names>A</given-names></name><name name-style="western"><surname>Staib</surname><given-names>C</given-names></name><name name-style="western"><surname>Garcon</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells</article-title>. <source>Blood</source>. (<year>2008</year>) <volume>111</volume>:<fpage>4653</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-11-123844</pub-id><pub-id pub-id-type="pmid">18316630</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name></person-group>. <article-title>Memory B cells: effectors of long-lived immune responses</article-title>. <source>Eur J Immunol</source>. (<year>2009</year>) <volume>39</volume>:<fpage>2065</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200939531</pub-id><pub-id pub-id-type="pmid">19637202</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>I</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>A</given-names></name><name name-style="western"><surname>Khoo</surname><given-names>WH</given-names></name><name name-style="western"><surname>Butt</surname><given-names>D</given-names></name><name name-style="western"><surname>Bourne</surname><given-names>K</given-names></name><name name-style="western"><surname>Young</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes</article-title>. <source>Nat Commun</source>. (<year>2018</year>) <volume>9</volume>:<fpage>3372</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-05772-7</pub-id><pub-id pub-id-type="pmid">30135429</pub-id><pub-id pub-id-type="pmcid">PMC6105623</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrasco</surname><given-names>YR</given-names></name><name name-style="western"><surname>Batista</surname><given-names>FD</given-names></name></person-group>. <article-title>B cells acquire particulate antigen in a macrophage-rich area at the boundary between the Follicle and the subcapsular sinus of the Lymph Node</article-title>. <source>Immunity</source>. (<year>2007</year>) <volume>27</volume>:<fpage>160</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2007.06.007</pub-id><pub-id pub-id-type="pmid">17658276</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phan</surname><given-names>TG</given-names></name><name name-style="western"><surname>Green</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gray</surname><given-names>EE</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation</article-title>. <source>Nat Immunol</source>. (<year>2009</year>) <volume>10</volume>:<fpage>786</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1745</pub-id><pub-id pub-id-type="pmid">19503106</pub-id><pub-id pub-id-type="pmcid">PMC2776777</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vajdy</surname><given-names>M</given-names></name><name name-style="western"><surname>Lycke</surname><given-names>N</given-names></name></person-group>. <article-title>Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant</article-title>. <source>Immunology</source>. (<year>1993</year>) <volume>80</volume>:<fpage>197</fpage>&#8211;<lpage>203</lpage>. <pub-id pub-id-type="pmid">7505255</pub-id><pub-id pub-id-type="pmcid">PMC1422185</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Barthelemy</surname><given-names>C</given-names></name><name name-style="western"><surname>De Bouteiller</surname><given-names>O</given-names></name><name name-style="western"><surname>Arpin</surname><given-names>C</given-names></name><name name-style="western"><surname>Durand</surname><given-names>I</given-names></name><name name-style="western"><surname>Banchereau</surname><given-names>J</given-names></name></person-group>. <article-title>Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2</article-title>. <source>Immunity</source>. (<year>1995</year>) <volume>2</volume>:<fpage>239</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/1074-7613(95)90048-9</pub-id><pub-id pub-id-type="pmid">7535180</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunn-Walters</surname><given-names>DK</given-names></name><name name-style="western"><surname>Isaacson</surname><given-names>PG</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>J</given-names></name></person-group>. <article-title>Sequence analysis of rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells</article-title>. <source>Immunology</source>. (<year>1996</year>) <volume>88</volume>:<fpage>618</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="pmid">8881766</pub-id><pub-id pub-id-type="pmcid">PMC1456619</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindner</surname><given-names>C</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>I</given-names></name><name name-style="western"><surname>Wahl</surname><given-names>B</given-names></name><name name-style="western"><surname>Ugur</surname><given-names>M</given-names></name><name name-style="western"><surname>Sethi</surname><given-names>MK</given-names></name><name name-style="western"><surname>Friedrichsen</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota</article-title>. <source>Nat Immunol</source>. (<year>2015</year>) <volume>16</volume>:<fpage>880</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3213</pub-id><pub-id pub-id-type="pmid">26147688</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bemark</surname><given-names>M</given-names></name><name name-style="western"><surname>Hazanov</surname><given-names>H</given-names></name><name name-style="western"><surname>Stromberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Komban</surname><given-names>R</given-names></name><name name-style="western"><surname>Holmqvist</surname><given-names>J</given-names></name><name name-style="western"><surname>Koster</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization</article-title>. <source>Nat Commun</source>. (<year>2016</year>) <volume>7</volume>:<fpage>12698</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12698</pub-id><pub-id pub-id-type="pmid">27596266</pub-id><pub-id pub-id-type="pmcid">PMC5025876</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahanonda</surname><given-names>R</given-names></name><name name-style="western"><surname>Champaiboon</surname><given-names>C</given-names></name><name name-style="western"><surname>Subbalekha</surname><given-names>K</given-names></name><name name-style="western"><surname>Sa-Ard-Iam</surname><given-names>N</given-names></name><name name-style="western"><surname>Rattanathammatada</surname><given-names>W</given-names></name><name name-style="western"><surname>Thawanaphong</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Human memory B cells in healthy gingiva, gingivitis, and periodontitis</article-title>. <source>J Immunol</source>. (<year>2016</year>) <volume>197</volume>:<fpage>715</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1600540</pub-id><pub-id pub-id-type="pmid">27335500</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joo</surname><given-names>HM</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sangster</surname><given-names>MY</given-names></name></person-group>. <article-title>Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2008</year>) <volume>105</volume>:<fpage>3485</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.0800003105</pub-id><pub-id pub-id-type="pmid">18299574</pub-id><pub-id pub-id-type="pmcid">PMC2265167</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onodera</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yokoi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ato</surname><given-names>M</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hachimura</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2012</year>) <volume>109</volume>:<fpage>2485</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1115369109</pub-id><pub-id pub-id-type="pmid">22308386</pub-id><pub-id pub-id-type="pmcid">PMC3289300</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allie</surname><given-names>SR</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>JE</given-names></name><name name-style="western"><surname>Mudunuru</surname><given-names>U</given-names></name><name name-style="western"><surname>Schultz</surname><given-names>MD</given-names></name><name name-style="western"><surname>Graf</surname><given-names>BA</given-names></name><name name-style="western"><surname>Lund</surname><given-names>FE</given-names></name><etal/></person-group>. <article-title>The establishment of resident memory B cells in the lung requires local antigen encounter</article-title>. <source>Nat Immunol</source>. (<year>2019</year>) <volume>20</volume>:<fpage>97</fpage>&#8211;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-018-0260-6</pub-id><pub-id pub-id-type="pmid">30510223</pub-id><pub-id pub-id-type="pmcid">PMC6392030</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Onodera</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Daio</surname><given-names>R</given-names></name><name name-style="western"><surname>Tsuiji</surname><given-names>M</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Distinct germinal center selection at local sites shapes memory B cell response to viral escape</article-title>. <source>J Exp Med</source>. (<year>2015</year>) <volume>212</volume>:<fpage>1709</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20142284</pub-id><pub-id pub-id-type="pmid">26324444</pub-id><pub-id pub-id-type="pmcid">PMC4577849</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dell</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lu</surname><given-names>YX</given-names></name><name name-style="western"><surname>Claflin</surname><given-names>JL</given-names></name></person-group>. <article-title>Molecular analysis of clonal stability and longevity in B cell memory</article-title>. <source>J Immunol</source>. (<year>1989</year>) <volume>143</volume>:<fpage>3364</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="pmid">2509556</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medina</surname><given-names>F</given-names></name><name name-style="western"><surname>Segundo</surname><given-names>C</given-names></name><name name-style="western"><surname>Campos-Caro</surname><given-names>A</given-names></name><name name-style="western"><surname>Gonzalez-Garcia</surname><given-names>I</given-names></name><name name-style="western"><surname>Brieva</surname><given-names>JA</given-names></name></person-group>. <article-title>The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression</article-title>. <source>Blood</source>. (<year>2002</year>) <volume>99</volume>:<fpage>2154</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V99.6.2154</pub-id><pub-id pub-id-type="pmid">11877292</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wrammert</surname><given-names>J</given-names></name><name name-style="western"><surname>Koutsonanos</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>GM</given-names></name><name name-style="western"><surname>Edupuganti</surname><given-names>S</given-names></name><name name-style="western"><surname>Sui</surname><given-names>J</given-names></name><name name-style="western"><surname>Morrissey</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection</article-title>. <source>J Exp Med</source>. (<year>2011</year>) <volume>208</volume>:<fpage>181</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20101352</pub-id><pub-id pub-id-type="pmid">21220454</pub-id><pub-id pub-id-type="pmcid">PMC3023136</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mcelroy</surname><given-names>AK</given-names></name><name name-style="western"><surname>Akondy</surname><given-names>RS</given-names></name><name name-style="western"><surname>Davis</surname><given-names>CW</given-names></name><name name-style="western"><surname>Ellebedy</surname><given-names>AH</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kraft</surname><given-names>CS</given-names></name><etal/></person-group>. <article-title>Human Ebola virus infection results in substantial immune activation</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2015</year>) <volume>112</volume>:<fpage>4719</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1502619112</pub-id><pub-id pub-id-type="pmid">25775592</pub-id><pub-id pub-id-type="pmcid">PMC4403189</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Wohlbold</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>NY</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Neu</surname><given-names>KE</given-names></name><etal/></person-group>. <article-title>Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies</article-title>. <source>Cell.</source> (<year>2018</year>) <volume>173</volume>:<fpage>417</fpage>&#8211;<lpage>29 e410</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.030</pub-id><pub-id pub-id-type="pmid">29625056</pub-id><pub-id pub-id-type="pmcid">PMC5890936</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>VT</given-names></name><name name-style="western"><surname>Berek</surname><given-names>C</given-names></name></person-group>. <article-title>The establishment of the plasma cell survival niche in the bone marrow</article-title>. <source>Immunol Rev</source>. (<year>2013</year>) <volume>251</volume>:<fpage>177</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12011</pub-id><pub-id pub-id-type="pmid">23278749</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arce</surname><given-names>S</given-names></name><name name-style="western"><surname>Luger</surname><given-names>E</given-names></name><name name-style="western"><surname>Muehlinghaus</surname><given-names>G</given-names></name><name name-style="western"><surname>Cassese</surname><given-names>G</given-names></name><name name-style="western"><surname>Hauser</surname><given-names>A</given-names></name><name name-style="western"><surname>Horst</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations</article-title>. <source>J Leukoc Biol</source>. (<year>2004</year>) <volume>75</volume>:<fpage>1022</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0603279</pub-id><pub-id pub-id-type="pmid">15020647</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odendahl</surname><given-names>M</given-names></name><name name-style="western"><surname>Mei</surname><given-names>H</given-names></name><name name-style="western"><surname>Hoyer</surname><given-names>BF</given-names></name><name name-style="western"><surname>Jacobi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>A</given-names></name><name name-style="western"><surname>Muehlinghaus</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response</article-title>. <source>Blood</source>. (<year>2005</year>) <volume>105</volume>:<fpage>1614</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2004-07-2507</pub-id><pub-id pub-id-type="pmid">15507523</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez-Garcia</surname><given-names>I</given-names></name><name name-style="western"><surname>Ocana</surname><given-names>E</given-names></name><name name-style="western"><surname>Jimenez-Gomez</surname><given-names>G</given-names></name><name name-style="western"><surname>Campos-Caro</surname><given-names>A</given-names></name><name name-style="western"><surname>Brieva</surname><given-names>JA</given-names></name></person-group>. <article-title>Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells</article-title>. <source>J Immunol</source>. (<year>2006</year>) <volume>176</volume>:<fpage>4042</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.7.4042</pub-id><pub-id pub-id-type="pmid">16547239</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>HE</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Sime</surname><given-names>W</given-names></name><name name-style="western"><surname>Hiepe</surname><given-names>F</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>K</given-names></name><name name-style="western"><surname>Manz</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Blood</italic>-borne human plasma cells in steady state are derived from mucosal immune responses</article-title>. <source>Blood</source>. (<year>2009</year>) <volume>113</volume>:<fpage>2461</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-04-153544</pub-id><pub-id pub-id-type="pmid">18987362</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>DC</given-names></name><name name-style="western"><surname>Garimalla</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Kyu</surname><given-names>S</given-names></name><name name-style="western"><surname>Albizua</surname><given-names>I</given-names></name><name name-style="western"><surname>Galipeau</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion</article-title>. <source>Nat Commun</source>. (<year>2018</year>) <volume>9</volume>:<fpage>3698</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-05853-7</pub-id><pub-id pub-id-type="pmid">30209264</pub-id><pub-id pub-id-type="pmcid">PMC6135805</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'connor</surname><given-names>BP</given-names></name><name name-style="western"><surname>Raman</surname><given-names>VS</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>LD</given-names></name><name name-style="western"><surname>Cook</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>LK</given-names></name><name name-style="western"><surname>Ahonen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>BCMA is essential for the survival of long-lived bone marrow plasma cells</article-title>. <source>J Exp Med</source>. (<year>2004</year>) <volume>199</volume>:<fpage>91</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20031330</pub-id><pub-id pub-id-type="pmid">14707116</pub-id><pub-id pub-id-type="pmcid">PMC1887725</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hargreaves</surname><given-names>DC</given-names></name><name name-style="western"><surname>Hyman</surname><given-names>PL</given-names></name><name name-style="western"><surname>Lu</surname><given-names>TT</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>VN</given-names></name><name name-style="western"><surname>Bidgol</surname><given-names>A</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>A coordinated change in chemokine responsiveness guides plasma cell movements</article-title>. <source>J Exp Med</source>. (<year>2001</year>) <volume>194</volume>:<fpage>45</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1084/jem.194.1.45</pub-id><pub-id pub-id-type="pmid">11435471</pub-id><pub-id pub-id-type="pmcid">PMC2193440</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>T</given-names></name><name name-style="western"><surname>Hieshima</surname><given-names>K</given-names></name><name name-style="western"><surname>Izawa</surname><given-names>D</given-names></name><name name-style="western"><surname>Tatsumi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kanamaru</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoshie</surname><given-names>O</given-names></name></person-group>. <article-title>Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues</article-title>. <source>J Immunol</source>. (<year>2003</year>) <volume>170</volume>:<fpage>1136</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.3.1136</pub-id><pub-id pub-id-type="pmid">12538668</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roldan</surname><given-names>E</given-names></name><name name-style="western"><surname>Garcia-Pardo</surname><given-names>A</given-names></name><name name-style="western"><surname>Brieva</surname><given-names>JA</given-names></name></person-group>. <article-title>VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion</article-title>. <source>J Exp Med</source>. (<year>1992</year>) <volume>175</volume>:<fpage>1739</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1084/jem.175.6.1739</pub-id><pub-id pub-id-type="pmid">1588291</pub-id><pub-id pub-id-type="pmcid">PMC2119256</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabera</surname><given-names>S</given-names></name><name name-style="western"><surname>Perez-Simon</surname><given-names>JA</given-names></name><name name-style="western"><surname>Diez-Campelo</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanchez-Abarca</surname><given-names>LI</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>B</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes</article-title>. <source>Haematologica</source>. (<year>2008</year>) <volume>93</volume>:<fpage>1301</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3324/haematol.12857</pub-id><pub-id pub-id-type="pmid">18641017</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonnaure</surname><given-names>G</given-names></name><name name-style="western"><surname>Gervais-St-Amour</surname><given-names>C</given-names></name><name name-style="western"><surname>Neron</surname><given-names>S</given-names></name></person-group>. <article-title>Bone marrow mesenchymal stem cells enhance the differentiation of human switched memory B lymphocytes into plasma cells in serum-free medium</article-title>. <source>J Immunol Res</source>. (<year>2016</year>) <volume>2016</volume>:<fpage>7801781</fpage>. <pub-id pub-id-type="doi">10.1155/2016/7801781</pub-id><pub-id pub-id-type="pmid">27872867</pub-id><pub-id pub-id-type="pmcid">PMC5107863</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belnoue</surname><given-names>E</given-names></name><name name-style="western"><surname>Pihlgren</surname><given-names>M</given-names></name><name name-style="western"><surname>Mcgaha</surname><given-names>TL</given-names></name><name name-style="western"><surname>Tougne</surname><given-names>C</given-names></name><name name-style="western"><surname>Rochat</surname><given-names>AF</given-names></name><name name-style="western"><surname>Bossen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells</article-title>. <source>Blood</source>. (<year>2008</year>) <volume>111</volume>:<fpage>2755</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-09-110858</pub-id><pub-id pub-id-type="pmid">18180376</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>DC</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>HC</given-names></name><name name-style="western"><surname>Joyner</surname><given-names>C</given-names></name><name name-style="western"><surname>Warren</surname><given-names>V</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Kissick</surname><given-names>HT</given-names></name><etal/></person-group>. <article-title>Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells</article-title>. <source>J Extracell Vesicles</source>. (<year>2018</year>) <volume>7</volume>:<fpage>1463778</fpage>. <pub-id pub-id-type="doi">10.1080/20013078.2018.1463778</pub-id><pub-id pub-id-type="pmid">29713426</pub-id><pub-id pub-id-type="pmcid">PMC5917896</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>HE</given-names></name><name name-style="western"><surname>Wirries</surname><given-names>I</given-names></name><name name-style="western"><surname>Frolich</surname><given-names>D</given-names></name><name name-style="western"><surname>Brisslert</surname><given-names>M</given-names></name><name name-style="western"><surname>Giesecke</surname><given-names>C</given-names></name><name name-style="western"><surname>Grun</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow</article-title>. <source>Blood</source>. (<year>2015</year>) <volume>125</volume>:<fpage>1739</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2014-02-555169</pub-id><pub-id pub-id-type="pmid">25573986</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arumugakani</surname><given-names>G</given-names></name><name name-style="western"><surname>Stephenson</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Newton</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Rawstron</surname><given-names>A</given-names></name><name name-style="western"><surname>Emery</surname><given-names>P</given-names></name><name name-style="western"><surname>Doody</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>Early emergence of CD19-negative human antibody-secreting cells at the plasmablast to plasma cell transition</article-title>. <source>J Immunol</source>. (<year>2017</year>) <volume>198</volume>:<fpage>4618</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1501761</pub-id><pub-id pub-id-type="pmid">28490574</pub-id><pub-id pub-id-type="pmcid">PMC5458329</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellyard</surname><given-names>JI</given-names></name><name name-style="western"><surname>Avery</surname><given-names>DT</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>CR</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name></person-group>. <article-title>Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54</article-title>. <source>Eur J Immunol</source>. (<year>2005</year>) <volume>35</volume>:<fpage>699</fpage>&#8211;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425442</pub-id><pub-id pub-id-type="pmid">15714584</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minges Wols</surname><given-names>HA</given-names></name><name name-style="western"><surname>Ippolito</surname><given-names>JA</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>JL</given-names></name><name name-style="western"><surname>White</surname><given-names>FA</given-names></name><name name-style="western"><surname>Le</surname><given-names>PT</given-names></name><etal/></person-group>. <article-title>The effects of microenvironment and internal programming on plasma cell survival</article-title>. <source>Int Immunol</source>. (<year>2007</year>) <volume>19</volume>:<fpage>837</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxm051</pub-id><pub-id pub-id-type="pmid">17606982</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Rivas-Caicedo</surname><given-names>A</given-names></name><name name-style="western"><surname>Renevey</surname><given-names>F</given-names></name><name name-style="western"><surname>Cannelle</surname><given-names>H</given-names></name><name name-style="western"><surname>Peranzoni</surname><given-names>E</given-names></name><name name-style="western"><surname>Scarpellino</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2018</year>) <volume>115</volume>:<fpage>E6826</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1712628115</pub-id><pub-id pub-id-type="pmid">29967180</pub-id><pub-id pub-id-type="pmcid">PMC6055158</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magri</surname><given-names>G</given-names></name><name name-style="western"><surname>Comerma</surname><given-names>L</given-names></name><name name-style="western"><surname>Pybus</surname><given-names>M</given-names></name><name name-style="western"><surname>Sintes</surname><given-names>J</given-names></name><name name-style="western"><surname>Llige</surname><given-names>D</given-names></name><name name-style="western"><surname>Segura-Garzon</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals</article-title>. <source>Immunity.</source> (<year>2017</year>) <volume>47</volume>:<fpage>118</fpage>&#8211;<lpage>34 e118</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.06.013</pub-id><pub-id pub-id-type="pmid">28709802</pub-id><pub-id pub-id-type="pmcid">PMC5519504</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>A</given-names></name><name name-style="western"><surname>Hulse</surname><given-names>KE</given-names></name><name name-style="western"><surname>Tan</surname><given-names>BK</given-names></name><name name-style="western"><surname>Schleimer</surname><given-names>RP</given-names></name></person-group>. <article-title>B-lymphocyte lineage cells and the respiratory system</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2013</year>) <volume>131</volume>:<fpage>933</fpage>&#8211;<lpage>57</lpage>; quiz 958. <pub-id pub-id-type="doi">10.1016/j.jaci.2013.02.023</pub-id><pub-id pub-id-type="pmid">23540615</pub-id><pub-id pub-id-type="pmcid">PMC3628816</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunker</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bendelac</surname><given-names>A</given-names></name></person-group>. <article-title>IgA Responses to Microbiota</article-title>. <source>Immunity</source>. (<year>2018</year>) <volume>49</volume>:<fpage>211</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.08.011</pub-id><pub-id pub-id-type="pmid">30134201</pub-id><pub-id pub-id-type="pmcid">PMC6107312</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>De Bouteiller</surname><given-names>O</given-names></name><name name-style="western"><surname>Arpin</surname><given-names>C</given-names></name><name name-style="western"><surname>Durand</surname><given-names>I</given-names></name><name name-style="western"><surname>Banchereau</surname><given-names>J</given-names></name></person-group>. <article-title>Five human mature B cell subsets</article-title>. <source>Adv Exp Med Biol</source>. (<year>1994</year>) <volume>355</volume>:<fpage>289</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4615-2492-2_49</pub-id><pub-id pub-id-type="pmid">7709838</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pascual</surname><given-names>V</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Magalski</surname><given-names>A</given-names></name><name name-style="western"><surname>De Bouteiller</surname><given-names>O</given-names></name><name name-style="western"><surname>Banchereau</surname><given-names>J</given-names></name><name name-style="western"><surname>Capra</surname><given-names>JD</given-names></name></person-group>. <article-title>Analysis of somatic mutation in five B cell subsets of human tonsil</article-title>. <source>J Exp Med</source>. (<year>1994</year>) <volume>180</volume>:<fpage>329</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1084/jem.180.1.329</pub-id><pub-id pub-id-type="pmid">8006591</pub-id><pub-id pub-id-type="pmcid">PMC2191579</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Arpin</surname><given-names>C</given-names></name></person-group>. <article-title>Germinal center development</article-title>. <source>Immunol Rev</source>. (<year>1997</year>) <volume>156</volume>:<fpage>111</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-065X.1997.tb00963.x</pub-id><pub-id pub-id-type="pmid">9280752</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giesecke</surname><given-names>C</given-names></name><name name-style="western"><surname>Frolich</surname><given-names>D</given-names></name><name name-style="western"><surname>Reiter</surname><given-names>K</given-names></name><name name-style="western"><surname>Mei</surname><given-names>HE</given-names></name><name name-style="western"><surname>Wirries</surname><given-names>I</given-names></name><name name-style="western"><surname>Kuhly</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells</article-title>. <source>J Immunol</source>. (<year>2014</year>) <volume>192</volume>:<fpage>3091</fpage>&#8211;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302783</pub-id><pub-id pub-id-type="pmid">24567530</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehrhardt</surname><given-names>GR</given-names></name><name name-style="western"><surname>Hijikata</surname><given-names>A</given-names></name><name name-style="western"><surname>Kitamura</surname><given-names>H</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>O</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>MD</given-names></name></person-group>. <article-title>Discriminating gene expression profiles of memory B cell subpopulations</article-title>. <source>J Exp Med</source>. (<year>2008</year>) <volume>205</volume>:<fpage>1807</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20072682</pub-id><pub-id pub-id-type="pmid">18625746</pub-id><pub-id pub-id-type="pmcid">PMC2525601</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuppers</surname><given-names>R</given-names></name></person-group>. <article-title>Human memory B cells: memory B cells of a special kind</article-title>. <source>Immunol Cell Biol</source>. (<year>2008</year>) <volume>86</volume>:<fpage>635</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/icb.2008.59</pub-id><pub-id pub-id-type="pmid">18695701</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>U</given-names></name><name name-style="western"><surname>Kuppers</surname><given-names>R</given-names></name><name name-style="western"><surname>Rajewsky</surname><given-names>K</given-names></name></person-group>. <article-title>Evidence for a large compartment of IgM-expressing memory B cells in humans</article-title>. <source>Blood</source>. (<year>1997</year>) <volume>89</volume>:<fpage>1288</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="pmid">9028952</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paramithiotis</surname><given-names>E</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>MD</given-names></name></person-group>. <article-title>Memory B lymphocytes migrate to bone marrow in humans</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1997</year>) <volume>94</volume>:<fpage>208</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.1.208</pub-id><pub-id pub-id-type="pmid">8990187</pub-id><pub-id pub-id-type="pmcid">PMC19286</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrion</surname><given-names>C</given-names></name><name name-style="western"><surname>Guerin</surname><given-names>E</given-names></name><name name-style="western"><surname>Gachard</surname><given-names>N</given-names></name><name name-style="western"><surname>Le Guyader</surname><given-names>A</given-names></name><name name-style="western"><surname>Giraut</surname><given-names>S</given-names></name><name name-style="western"><surname>Feuillard</surname><given-names>J</given-names></name></person-group>. <article-title>Adult bone marrow three-dimensional phenotypic landscape of B-cell differentiation</article-title>. <source>Cytometry B Clin Cytom</source>. (<year>2019</year>) <volume>96</volume>:<fpage>30</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.b.21747</pub-id><pub-id pub-id-type="pmid">30450798</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timens</surname><given-names>W</given-names></name><name name-style="western"><surname>Poppema</surname><given-names>S</given-names></name></person-group>. <article-title>Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease</article-title>. <source>Am J Pathol</source>. (<year>1985</year>) <volume>120</volume>:<fpage>443</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="pmid">3898859</pub-id><pub-id pub-id-type="pmcid">PMC1887979</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith-Ravin</surname><given-names>J</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>J</given-names></name><name name-style="western"><surname>Beverley</surname><given-names>PC</given-names></name><name name-style="western"><surname>Isaacson</surname><given-names>PG</given-names></name></person-group>. <article-title>Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells</article-title>. <source>Clin Exp Immunol</source>. (<year>1990</year>) <volume>82</volume>:<fpage>181</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.1990.tb05424.x</pub-id><pub-id pub-id-type="pmid">2208792</pub-id><pub-id pub-id-type="pmcid">PMC1535176</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraal</surname><given-names>G</given-names></name></person-group>. <article-title>Cells in the marginal zone of the spleen</article-title>. <source>Int Rev Cytol</source>. (<year>1992</year>) <volume>132</volume>:<fpage>31</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7696(08)62453-5</pub-id><pub-id pub-id-type="pmid">1555921</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangye</surname><given-names>SG</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Aversa</surname><given-names>G</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>JH</given-names></name><name name-style="western"><surname>De Vries</surname><given-names>JE</given-names></name></person-group>. <article-title>Identification of functional human splenic memory B cells by expression of CD148 and CD27</article-title>. <source>J Exp Med</source>. (<year>1998</year>) <volume>188</volume>:<fpage>1691</fpage>&#8211;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1084/jem.188.9.1691</pub-id><pub-id pub-id-type="pmid">9802981</pub-id><pub-id pub-id-type="pmcid">PMC2212517</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ettinger</surname><given-names>R</given-names></name><name name-style="western"><surname>Sims</surname><given-names>GP</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>R</given-names></name><name name-style="western"><surname>Withers</surname><given-names>D</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>RT</given-names></name><name name-style="western"><surname>Grammer</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells</article-title>. <source>J Immunol</source>. (<year>2007</year>) <volume>178</volume>:<fpage>2872</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.5.2872</pub-id><pub-id pub-id-type="pmid">17312131</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kruetzmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Rosado</surname><given-names>MM</given-names></name><name name-style="western"><surname>Weber</surname><given-names>H</given-names></name><name name-style="western"><surname>Germing</surname><given-names>U</given-names></name><name name-style="western"><surname>Tournilhac</surname><given-names>O</given-names></name><name name-style="western"><surname>Peter</surname><given-names>HH</given-names></name><etal/></person-group>. <article-title>Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen</article-title>. <source>J Exp Med</source>. (<year>2003</year>) <volume>197</volume>:<fpage>939</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20022020</pub-id><pub-id pub-id-type="pmid">12682112</pub-id><pub-id pub-id-type="pmcid">PMC2193885</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weller</surname><given-names>S</given-names></name><name name-style="western"><surname>Braun</surname><given-names>MC</given-names></name><name name-style="western"><surname>Tan</surname><given-names>BK</given-names></name><name name-style="western"><surname>Rosenwald</surname><given-names>A</given-names></name><name name-style="western"><surname>Cordier</surname><given-names>C</given-names></name><name name-style="western"><surname>Conley</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Human blood IgM &#8220;memory&#8221; B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire</article-title>. <source>Blood</source>. (<year>2004</year>) <volume>104</volume>:<fpage>3647</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2004-01-0346</pub-id><pub-id pub-id-type="pmid">15191950</pub-id><pub-id pub-id-type="pmcid">PMC2590648</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weill</surname><given-names>JC</given-names></name><name name-style="western"><surname>Weller</surname><given-names>S</given-names></name><name name-style="western"><surname>Reynaud</surname><given-names>CA</given-names></name></person-group>. <article-title>Human marginal zone B cells</article-title>. <source>Annu Rev Immunol</source>. (<year>2009</year>) <volume>27</volume>:<fpage>267</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132607</pub-id><pub-id pub-id-type="pmid">19302041</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weller</surname><given-names>S</given-names></name><name name-style="western"><surname>Mamani-Matsuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Picard</surname><given-names>C</given-names></name><name name-style="western"><surname>Cordier</surname><given-names>C</given-names></name><name name-style="western"><surname>Lecoeuche</surname><given-names>D</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants</article-title>. <source>J Exp Med</source>. (<year>2008</year>) <volume>205</volume>:<fpage>1331</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20071555</pub-id><pub-id pub-id-type="pmid">18519648</pub-id><pub-id pub-id-type="pmcid">PMC2413031</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagnara</surname><given-names>D</given-names></name><name name-style="western"><surname>Squillario</surname><given-names>M</given-names></name><name name-style="western"><surname>Kipling</surname><given-names>D</given-names></name><name name-style="western"><surname>Mora</surname><given-names>T</given-names></name><name name-style="western"><surname>Walczak</surname><given-names>AM</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>A Reassessment of IgM Memory Subsets in Humans</article-title>. <source>J Immunol</source>. (<year>2015</year>) <volume>195</volume>:<fpage>3716</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1500753</pub-id><pub-id pub-id-type="pmid">26355154</pub-id><pub-id pub-id-type="pmcid">PMC4594759</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litinskiy</surname><given-names>MB</given-names></name><name name-style="western"><surname>Nardelli</surname><given-names>B</given-names></name><name name-style="western"><surname>Hilbert</surname><given-names>DM</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Schaffer</surname><given-names>A</given-names></name><name name-style="western"><surname>Casali</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL</article-title>. <source>Nat Immunol.</source> (<year>2002</year>) <volume>3</volume>:<fpage>822</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ni829</pub-id><pub-id pub-id-type="pmid">12154359</pub-id><pub-id pub-id-type="pmcid">PMC4621779</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>RM</given-names></name><name name-style="western"><surname>Meyer Sauteur</surname><given-names>PM</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>DF</given-names></name><name name-style="western"><surname>Truck</surname><given-names>J</given-names></name></person-group>. <article-title>The antibody-secreting cell response to infection: kinetics and clinical applications</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<fpage>630</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00630</pub-id><pub-id pub-id-type="pmid">28620385</pub-id><pub-id pub-id-type="pmcid">PMC5451496</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrante</surname><given-names>A</given-names></name><name name-style="western"><surname>Beard</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>RG</given-names></name></person-group>. <article-title>IgG subclass distribution of antibodies to bacterial and viral antigens</article-title>. <source>Pediatr Infect Dis J</source>. (<year>1990</year>) <volume>9</volume>:<fpage>S16</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1097/00006454-199008001-00004</pub-id><pub-id pub-id-type="pmid">2216603</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siber</surname><given-names>GR</given-names></name><name name-style="western"><surname>Schur</surname><given-names>PH</given-names></name><name name-style="western"><surname>Aisenberg</surname><given-names>AC</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>SA</given-names></name><name name-style="western"><surname>Schiffman</surname><given-names>G</given-names></name></person-group>. <article-title>Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens</article-title>. <source>N Engl J Med</source>. (<year>1980</year>) <volume>303</volume>:<fpage>178</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198007243030402</pub-id><pub-id pub-id-type="pmid">6966763</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidarsson</surname><given-names>G</given-names></name><name name-style="western"><surname>Dekkers</surname><given-names>G</given-names></name><name name-style="western"><surname>Rispens</surname><given-names>T</given-names></name></person-group>. <article-title>IgG subclasses and allotypes: from structure to effector functions</article-title>. <source>Front Immunol</source>. (<year>2014</year>) <volume>5</volume>:<fpage>520</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00520</pub-id><pub-id pub-id-type="pmid">25368619</pub-id><pub-id pub-id-type="pmcid">PMC4202688</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerutti</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Chorny</surname><given-names>A</given-names></name></person-group>. <article-title>Immunoglobulin responses at the mucosal interface</article-title>. <source>Annu Rev Immunol</source>. (<year>2011</year>) <volume>29</volume>:<fpage>273</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101317</pub-id><pub-id pub-id-type="pmid">21219173</pub-id><pub-id pub-id-type="pmcid">PMC3064559</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Santini</surname><given-names>PA</given-names></name><name name-style="western"><surname>Polydorides</surname><given-names>AD</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>A</given-names></name><name name-style="western"><surname>Estrella</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL</article-title>. <source>Immunity.</source> (<year>2007</year>) <volume>26</volume>:<fpage>812</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.014</pub-id><pub-id pub-id-type="pmid">17570691</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moldoveanu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Clements</surname><given-names>ML</given-names></name><name name-style="western"><surname>Prince</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>BR</given-names></name><name name-style="western"><surname>Mestecky</surname><given-names>J</given-names></name></person-group><article-title>Human immune responses to influenza virus vaccines administered by systemic or mucosal routes</article-title>. <source>Vaccine</source>. (<year>1995</year>) <volume>13</volume>:<fpage>1006</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(95)00016-T</pub-id><pub-id pub-id-type="pmid">8525683</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>GM</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wrammert</surname><given-names>J</given-names></name><name name-style="western"><surname>Mccausland</surname><given-names>M</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>SF</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>NY</given-names></name><etal/></person-group>. <article-title>Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2012</year>) <volume>109</volume>:<fpage>9047</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1118979109</pub-id><pub-id pub-id-type="pmid">22615367</pub-id><pub-id pub-id-type="pmcid">PMC3384143</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jegaskanda</surname><given-names>S</given-names></name><name name-style="western"><surname>Mason</surname><given-names>RD</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>SF</given-names></name><name name-style="western"><surname>Wheatley</surname><given-names>AK</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Reynoso</surname><given-names>GV</given-names></name><etal/></person-group>. <article-title>Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes</article-title>. <source>J Virol</source>. (<year>2018</year>) <volume>92</volume>:<fpage>e01970</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01970-17</pub-id><pub-id pub-id-type="pmid">29444938</pub-id><pub-id pub-id-type="pmcid">PMC5899203</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Bricault</surname><given-names>CA</given-names></name><name name-style="western"><surname>Borducchi</surname><given-names>EN</given-names></name><name name-style="western"><surname>Stephenson</surname><given-names>KE</given-names></name><name name-style="western"><surname>Seaman</surname><given-names>MS</given-names></name><name name-style="western"><surname>Pau</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys</article-title>. <source>J Virol</source>. (<year>2018</year>) <volume>92</volume>:<lpage>e00537</lpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00537-18</pub-id><pub-id pub-id-type="pmid">29793950</pub-id><pub-id pub-id-type="pmcid">PMC6052297</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>HE</given-names></name><name name-style="western"><surname>Frolich</surname><given-names>D</given-names></name><name name-style="western"><surname>Giesecke</surname><given-names>C</given-names></name><name name-style="western"><surname>Loddenkemper</surname><given-names>C</given-names></name><name name-style="western"><surname>Reiter</surname><given-names>K</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab</article-title>. <source>Blood</source>. (<year>2010</year>) <volume>116</volume>:<fpage>5181</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-01-266536</pub-id><pub-id pub-id-type="pmid">20829370</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iversen</surname><given-names>R</given-names></name><name name-style="western"><surname>Snir</surname><given-names>O</given-names></name><name name-style="western"><surname>Stensland</surname><given-names>M</given-names></name><name name-style="western"><surname>Kroll</surname><given-names>JE</given-names></name><name name-style="western"><surname>Steinsbo</surname><given-names>O</given-names></name><name name-style="western"><surname>Korponay-Szabo</surname><given-names>IR</given-names></name><etal/></person-group>. <article-title>Strong clonal relatedness between serum and gut IgA despite different plasma cell origins</article-title>. <source>Cell Rep</source>. (<year>2017</year>) <volume>20</volume>:<fpage>2357</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.036</pub-id><pub-id pub-id-type="pmid">28877470</pub-id><pub-id pub-id-type="pmcid">PMC5603730</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neu</surname><given-names>KE</given-names></name><name name-style="western"><surname>Guthmiller</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M</given-names></name><name name-style="western"><surname>La</surname><given-names>J</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination</article-title>. <source>J Clin Invest</source>. (<year>2018</year>). <pub-id pub-id-type="doi">10.1172/JCI121341</pub-id><pub-id pub-id-type="pmid">30457979</pub-id><pub-id pub-id-type="pmcid">PMC6307935</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patricia</surname><given-names>D'souza M</given-names></name><name name-style="western"><surname>Allen</surname><given-names>MA</given-names></name><name name-style="western"><surname>Baumblatt</surname><given-names>JAG</given-names></name><name name-style="western"><surname>Boggiano</surname><given-names>C</given-names></name><name name-style="western"><surname>Crotty</surname><given-names>S</given-names></name><name name-style="western"><surname>Lymph Node Webinar</surname><given-names>C</given-names></name><etal/></person-group><article-title>Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials</article-title>. <source>Vaccine</source>. (<year>2018</year>) <volume>36</volume>:<fpage>5671</fpage>&#8211;<lpage>5677</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.07.071</pub-id><pub-id pub-id-type="pmid">30097219</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hill</surname><given-names>DL</given-names></name></person-group>. <article-title>Can follicular helper T cells be targeted to improve vaccine efficacy?</article-title><source>F1000Res</source>. (<year>2016</year>) <volume>5</volume>:<fpage>88</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.7388.1</pub-id><pub-id pub-id-type="pmid">26989476</pub-id><pub-id pub-id-type="pmcid">PMC4784016</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bart</surname><given-names>PA</given-names></name><name name-style="western"><surname>Meuwly</surname><given-names>JY</given-names></name><name name-style="western"><surname>Corpataux</surname><given-names>JM</given-names></name><name name-style="western"><surname>Yerly</surname><given-names>S</given-names></name><name name-style="western"><surname>Rizzardi</surname><given-names>P</given-names></name><name name-style="western"><surname>Fleury</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients</article-title>. <source>Swiss HIV Cohort Study AIDS</source>. (<year>1999</year>) <volume>13</volume>:<fpage>1503</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/00002030-199908200-00010</pub-id><pub-id pub-id-type="pmid">10465074</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name name-style="western"><surname>Carnathan</surname><given-names>DG</given-names></name><name name-style="western"><surname>Torrents De La Pena</surname><given-names>A</given-names></name><name name-style="western"><surname>Pauthner</surname><given-names>M</given-names></name><name name-style="western"><surname>Briney</surname><given-names>B</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV env trimer</article-title>. <source>Cell Rep</source>. (<year>2016</year>) <volume>17</volume>:<fpage>2195</fpage>&#8211;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.085</pub-id><pub-id pub-id-type="pmid">27880897</pub-id><pub-id pub-id-type="pmcid">PMC5142765</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirelli</surname><given-names>KM</given-names></name><name name-style="western"><surname>Crotty</surname><given-names>S</given-names></name></person-group>. <article-title>Germinal center enhancement by extended antigen availability</article-title>. <source>Curr Opin Immunol</source>. (<year>2017</year>) <volume>47</volume>:<fpage>64</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2017.06.008</pub-id><pub-id pub-id-type="pmid">28738289</pub-id><pub-id pub-id-type="pmcid">PMC5626612</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haynes</surname><given-names>BF</given-names></name><name name-style="western"><surname>Kelsoe</surname><given-names>G</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kepler</surname><given-names>TB</given-names></name></person-group>. <article-title>B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study</article-title>. <source>Nat Biotechnol</source>. (<year>2012</year>) <volume>30</volume>:<fpage>423</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2197</pub-id><pub-id pub-id-type="pmid">22565972</pub-id><pub-id pub-id-type="pmcid">PMC3512202</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dimitrov</surname><given-names>DS</given-names></name></person-group>. <article-title>Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies</article-title>. <source>Viruses</source>. (<year>2009</year>) <volume>1</volume>:<fpage>802</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3390/v1030802</pub-id><pub-id pub-id-type="pmid">21994570</pub-id><pub-id pub-id-type="pmcid">PMC3185542</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Prabakaran</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2009</year>) <volume>390</volume>:<fpage>404</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2009.09.029</pub-id><pub-id pub-id-type="pmid">19748484</pub-id><pub-id pub-id-type="pmcid">PMC2787893</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonsignori</surname><given-names>M</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>KK</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Tsao</surname><given-names>CY</given-names></name><name name-style="western"><surname>Morris</surname><given-names>L</given-names></name><name name-style="western"><surname>Gray</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors</article-title>. <source>J Virol</source>. (<year>2011</year>) <volume>85</volume>:<fpage>9998</fpage>&#8211;<lpage>10009</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.05045-11</pub-id><pub-id pub-id-type="pmid">21795340</pub-id><pub-id pub-id-type="pmcid">PMC3196428</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Alam</surname><given-names>SM</given-names></name><name name-style="western"><surname>Go</surname><given-names>EP</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Desaire</surname><given-names>H</given-names></name><name name-style="western"><surname>Tomaras</surname><given-names>GD</given-names></name><etal/></person-group>. <article-title>Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies</article-title>. <source>PLoS Pathog</source>. (<year>2011</year>) <volume>7</volume>:<fpage>e1002200</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002200</pub-id><pub-id pub-id-type="pmid">21909262</pub-id><pub-id pub-id-type="pmcid">PMC3164629</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>RK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Menis</surname><given-names>S</given-names></name><name name-style="western"><surname>Skog</surname><given-names>P</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ota</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens</article-title>. <source>Immunity</source>. (<year>2018</year>) <volume>48</volume>:<fpage>133</fpage>&#8211;<lpage>46 e136</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.023</pub-id><pub-id pub-id-type="pmid">29287996</pub-id><pub-id pub-id-type="pmcid">PMC5773359</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellebedy</surname><given-names>AH</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Kissick</surname><given-names>HT</given-names></name><name name-style="western"><surname>Nakaya</surname><given-names>HI</given-names></name><name name-style="western"><surname>Davis</surname><given-names>CW</given-names></name><name name-style="western"><surname>Roskin</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination</article-title>. <source>Nat Immunol</source>. (<year>2016</year>) <volume>17</volume>:<fpage>1226</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3533</pub-id><pub-id pub-id-type="pmid">27525369</pub-id><pub-id pub-id-type="pmcid">PMC5054979</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>D</given-names></name><name name-style="western"><surname>Lan</surname><given-names>LY</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>SF</given-names></name><name name-style="western"><surname>Henry</surname><given-names>C</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>KT</given-names></name><name name-style="western"><surname>Neu</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Low CD21 xpression defines a population of recent germinal center graduates primed for plasma cell differentiation</article-title>. <source>Sci Immunol</source>. (<year>2017</year>) <volume>2</volume>:<fpage>eaai8153</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aai8153</pub-id><pub-id pub-id-type="pmid">28783670</pub-id><pub-id pub-id-type="pmcid">PMC5896567</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koutsakos</surname><given-names>M</given-names></name><name name-style="western"><surname>Wheatley</surname><given-names>AK</given-names></name><name name-style="western"><surname>Loh</surname><given-names>L</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>EB</given-names></name><name name-style="western"><surname>Sant</surname><given-names>S</given-names></name><name name-style="western"><surname>Nussing</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity</article-title>. <source>Sci Transl Med</source>. (<year>2018</year>) <volume>10</volume>:<fpage>eaan8405</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aan8405</pub-id><pub-id pub-id-type="pmid">29444980</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>S</given-names></name><name name-style="western"><surname>Mohn</surname><given-names>KG</given-names></name><name name-style="western"><surname>Krammer</surname><given-names>F</given-names></name><name name-style="western"><surname>Sanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Bredholt</surname><given-names>G</given-names></name><name name-style="western"><surname>Jul-Larsen</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination</article-title>. <source>Vaccine</source>. (<year>2017</year>) <volume>35</volume>:<fpage>5666</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.08.044</pub-id><pub-id pub-id-type="pmid">28899626</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babu</surname><given-names>TM</given-names></name><name name-style="western"><surname>Levine</surname><given-names>M</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>T</given-names></name><name name-style="western"><surname>Luke</surname><given-names>C</given-names></name><name name-style="western"><surname>Sangster</surname><given-names>MY</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine</article-title>. <source>Vaccine</source>. (<year>2014</year>) <volume>32</volume>:<fpage>6798</fpage>&#8211;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.09.070</pub-id><pub-id pub-id-type="pmid">25446831</pub-id><pub-id pub-id-type="pmcid">PMC9002966</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talaat</surname><given-names>KR</given-names></name><name name-style="western"><surname>Luke</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Khurana</surname><given-names>S</given-names></name><name name-style="western"><surname>Manischewitz</surname><given-names>J</given-names></name><name name-style="western"><surname>King</surname><given-names>LR</given-names></name><name name-style="western"><surname>Mcmahon</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response</article-title>. <source>J Infect Dis</source>. (<year>2014</year>) <volume>209</volume>:<fpage>1860</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu123</pub-id><pub-id pub-id-type="pmid">24604819</pub-id><pub-id pub-id-type="pmcid">PMC4047295</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobhanie</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsuoka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jegaskanda</surname><given-names>S</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>T</given-names></name><name name-style="western"><surname>Mallory</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)</article-title>. <source>J Infect Dis</source>. (<year>2016</year>) <volume>213</volume>:<fpage>922</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiv526</pub-id><pub-id pub-id-type="pmid">26655841</pub-id><pub-id pub-id-type="pmcid">PMC4760421</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tritto</surname><given-names>E</given-names></name><name name-style="western"><surname>Mosca</surname><given-names>F</given-names></name><name name-style="western"><surname>De Gregorio</surname><given-names>E</given-names></name></person-group>. <article-title>Mechanism of action of licensed vaccine adjuvants</article-title>. <source>Vaccine</source>. (<year>2009</year>) <volume>27</volume>:<fpage>3331</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.084</pub-id><pub-id pub-id-type="pmid">19200813</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domnich</surname><given-names>A</given-names></name><name name-style="western"><surname>Arata</surname><given-names>L</given-names></name><name name-style="western"><surname>Amicizia</surname><given-names>D</given-names></name><name name-style="western"><surname>Puig-Barbera</surname><given-names>J</given-names></name><name name-style="western"><surname>Gasparini</surname><given-names>R</given-names></name><name name-style="western"><surname>Panatto</surname><given-names>D</given-names></name></person-group>. <article-title>Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis</article-title>. <source>Vaccine</source>. (<year>2017</year>) <volume>35</volume>:<fpage>513</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.12.011</pub-id><pub-id pub-id-type="pmid">28024956</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>TWY</given-names></name><name name-style="western"><surname>Cowling</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Gao</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>MG</given-names></name></person-group>. <article-title>Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis</article-title>. <source>J Infect Dis</source>. (<year>2018</year>). <pub-id pub-id-type="doi">10.1093/infdis/jiy720</pub-id><pub-id pub-id-type="pmid">30551178</pub-id><pub-id pub-id-type="pmcid">PMC6775043</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vesikari</surname><given-names>T</given-names></name><name name-style="western"><surname>Kirstein</surname><given-names>J</given-names></name><name name-style="western"><surname>Devota Go</surname><given-names>G</given-names></name><name name-style="western"><surname>Leav</surname><given-names>B</given-names></name><name name-style="western"><surname>Ruzycky</surname><given-names>ME</given-names></name><name name-style="western"><surname>Isakov</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial</article-title>. <source>Lancet Respir Med</source>. (<year>2018</year>) <volume>6</volume>:<fpage>345</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(18)30108-5</pub-id><pub-id pub-id-type="pmid">29631857</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galson</surname><given-names>JD</given-names></name><name name-style="western"><surname>Truck</surname><given-names>J</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>DF</given-names></name><name name-style="western"><surname>Van Der Most</surname><given-names>R</given-names></name></person-group>. <article-title>Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>37229</fpage>. <pub-id pub-id-type="doi">10.1038/srep37229</pub-id><pub-id pub-id-type="pmid">27849037</pub-id><pub-id pub-id-type="pmcid">PMC5110968</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>